CN1258282A - Parasiticidal pyrazoles - Google Patents

Parasiticidal pyrazoles Download PDF

Info

Publication number
CN1258282A
CN1258282A CN97180334A CN97180334A CN1258282A CN 1258282 A CN1258282 A CN 1258282A CN 97180334 A CN97180334 A CN 97180334A CN 97180334 A CN97180334 A CN 97180334A CN 1258282 A CN1258282 A CN 1258282A
Authority
CN
China
Prior art keywords
phenyl
pyrazoles
cyano group
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN97180334A
Other languages
Chinese (zh)
Other versions
CN1106386C (en
Inventor
B·J·班克斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625290.3A external-priority patent/GB9625290D0/en
Priority claimed from GBGB9702235.4A external-priority patent/GB9702235D0/en
Priority claimed from GBGB9712045.5A external-priority patent/GB9712045D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1258282A publication Critical patent/CN1258282A/en
Application granted granted Critical
Publication of CN1106386C publication Critical patent/CN1106386C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)

Abstract

Compounds of formula (I) or pharmaceutically, veterinarily or agriculturally acceptable salts thereof, or pharmaceutically, veterinarily or agriculturally acceptable solvates of either entity, wherein R<1> is 2,4,6-trisubstituted phenyl or 3,5-disubstituted pyridin-2-yl; R<3> is C1-C4 alkyl optionally substituted with hydroxy or with one or more halo; cyano, C1 to C5 alkanoyl or phenyl; R<5> is hydrogen, C1 to C4 alkyl, amino or halo; R<2> and R<4> are each independently selected from hydrogen, C1 to C4 alkyl, fluoro, chloro and bromo or, together with the carbon atom to which they are attached, form a C3 to C6 cycloalkyl group; R<6> and R<8> are each independently selected from hydrogen, C1 to C4 alkyl, fluoro, chloro and bromo; or, when R<2> and R<4> do not form part of a cycloalkyl group, R<2> and R<6>, together with the carbon atoms to which they are attached, may form a C5 to C7 cycloalkyl group; and R<7> is hydrogen, C1 to C4 alkyl optionally substituted with one or more halo, or C1 to C4 alkoxy; are parasiticidal agents.

Description

Parasiticidal pyrazole compound
The present invention relates to have the pyrazole derivatives of Parasiticidal characteristic.More particularly, the present invention relates to 1-aryl-4-cyclopropyl pyrazole compound.
Some particularly has the active pyrazole compound of Parasiticidal is known.For example, EP-A-0234119 discloses the 1-arylpyrazole compounds that is used to prevent and treat arthropods, Plant nematode and worm insect.Also disclose 1-arylpyrazole compounds among the EP-A-0295117, except having Arthropodicidal, plant nematocide and anthelmintic activity, these compounds also have antiprotozoal characteristic according to reports.Also disclose among the EP-A-0295118 and had similar active 1-arylpyrazole compounds.
The invention provides on following formula (I) compound or its medicine, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on acceptable solvent thing (comprising hydrate):
Figure A9718033400101
R wherein 1Be 2,4, the 6-trisubstd phenyl, wherein 2-and 6-substituting group are selected from halogen and 4-substituting group independently of one another and are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls (pentafluorothio); Or 3,5-Disubstituted pyridine-2-base, wherein the 3-substituting group is that halogen and 5-substituting group are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls; R 3Be can be by hydroxyl or the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, cyano group, C 1-C 5Alkanoyl or phenyl; R 5Be hydrogen, C 1-C 4Alkyl, amino or halogen; R 2And R 4Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, chlorine and bromine perhaps form C with the carbon atom that they connected 3-C 6Cycloalkyl; R 6And R 8Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, fluorine and bromine; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form C with the carbon atom that they connected 5-C 7Cycloalkyl; R 7The C that is hydrogen, can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, or C 1-C 4Alkoxyl group; With n be 0,1 or 2.
In above-mentioned definition, except as otherwise noted, having the alkyl and the alkoxyl group of three or more carbon atom and have four or a plurality of carbon atom chain alkyloyl can be straight or branched; Halogen is meant fluorine, chlorine, bromine or iodine.
Therefore described formula (I) compound can contain one or more chiral centres and can exist with stereoisomer form, for example enantiomorph or diastereomer, and their mixture.The present invention includes each steric isomer of described formula (I) compound and their mixture.The separation of diastereomer can realize by ordinary method, for example chromatographic separation (the comprising HPLC) fractional crystallization of the non-enantiomer mixture of through type (I) compound or its suitable salt or derivative.Each enantiomorph of formula (I) compound all can split preparation by racemoid being carried out HPLC by corresponding optical purity intermediate preparation or with suitable chiral support, perhaps, if suitable, by the diastereoisomeric salt fractional crystallization preparation that racemoid and the optical activity acid-respons that suits are formed.
The present invention also comprises the radio-labeling derivative of formula (I) compound applicable to biological study.
On described formula (I) compound medicine, the animal doctor is last and agriculture acceptable salt for example with mineral acid hydrochloric acid, Hydrogen bromide, sulfuric acid and the phosphoric acid non-toxic acid additive salt that forms, form with organic carboxyl acid or organic sulfonic acid for example.The situation of suitable salt can be referring to J.Pharm.Sci., and 1977,66,1.
Preferred one group of formula (I) compound is R wherein 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-five fluorine sulfenyl phenyl, 2,4,6-trichlorophenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be methyl, ethyl, third-2-base, 1-hydroxyethyl, 2-hydroxypropyl-2-base, difluoromethyl, dichloromethyl, trifluoromethyl, cyano group, formyl radical, ethanoyl or phenyl; R 5Be hydrogen, methyl, amino or chlorine; R 2And R 4Be selected from hydrogen, methyl, fluorine, chlorine and bromine independently of one another, perhaps form cyclopropyl, cyclobutyl or cyclopentyl with the carbon atom that they connected; R 6And R 8Be selected from hydrogen, methyl, chlorine and bromine independently of one another; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form pentamethylene or hexanaphthene with the carbon atom that they connected; And R 7It is the compound of hydrogen, methyl, ethyl, trifluoromethyl, chlorodifluoramethyl-, pentafluoroethyl group, seven fluoropropyls or methoxyl group.
Preferred one group of formula (I) compound is R wherein 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-, five fluorine sulfenyl phenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be cyano group; R 5Be hydrogen or amino; R 2And R 4Identical and be hydrogen, chlorine or bromine; R 6And R 8Be hydrogen; And R 7It is the compound of hydrogen, trifluoromethyl or chlorodifluoramethyl-.
The particularly preferred particular compound of the present invention comprises
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
(-)-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles;
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
4-(1-chlorodifluoramethyl-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
1-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-(2,2-dibromo cyclopropyl)-pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles; With
5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles.
On the other hand, as mentioned below, the invention provides on formula (I) compound or its medicine, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on acceptable solvent thing (comprising hydrate) preparation method.It will be understood by those skilled in the art that; in a certain described method; the order of used synthesis step can change and except other situations, will depend on factors such as the availability of the kind of other functional groups that for example exist, key intermediate and the protecting group of taking in advance (if any) method in specific reactants.Obviously, these factors also can influence the selection of agents useful for same in described synthesis step.Will also be appreciated that in certain same form (I) compound various different substituents or functional group change and conversion will obtain other formulas (I) compound.For example, R wherein 5Be the deamination of formula (I) compound of amino, wherein R 2And R 4Be the single debromination and the R wherein of formula (I) compound of bromine 3Formula (I) compound that is cyano group is transformed into wherein R 3Be C 1-C 5The formula of alkanoyl (I) compound, wherein R 3Be C 1-C 4The formula of alkanoyl (I) compound is transformed into wherein R 3Replaced by hydroxyl or by dihalogenated C 1-C 4The formula of alkyl (I) compound and R wherein 3Formula (I) compound of the alkyl that is replaced by hydroxyl is transformed into wherein R 3Be C 1-C 4Alkyl or by the monobasic C of halogen 1-C 4The formula of alkyl (I) compound.
Therefore, what follows method has been illustrated in order to obtain the general synthetic method that compound of the present invention can adopt.1. formula (I) compound can pass through the Cyclopropanated preparation of following formula (II) alkene:
Figure A9718033400131
R wherein 1, R 3, R 5, R 6, R 7And R 8As definition in the above-mentioned formula (I).It can in the presence of formula (II) compound, be finished by generating required carbenoid species matter on the spot with suitable method.This method comprises preferably in the presence of phase-transfer catalyst, with alkaline purification chloroform or bromofom, the Organometallic precursor that thermolysis suits is aryl trichloromethyl or trisbromomethyl mercury derivative for example, handling with diazonium paraffin in the presence of the phase-transfer catalyst and do not having in the presence of the phase-transfer catalyst with diazonium paraffin processing, the described intermediate pyrazoline of thermolysis subsequently.
For example, in first method, in order to prepare wherein R 2And R 4Both are formula (I) compound of chlorine or bromine, in the presence of formula (II) compound and quaternary ammonium salt, room temperature to about reflux temperature of reaction medium in suitable solvent, handle chloroform or bromofom respectively with the concentrated aqueous solutions of alkali metal hydroxide.Preferably, described reagent is respectively sodium hydroxide and benzyl triethylammonium chloride, and described solvent preferably at random has the methylene dichloride of small amount of ethanol.
For example, in the second approach, in order to prepare wherein R 2And R 4Both are formula (I) compound of chlorine or bromine, in the preferred toluene of suitable solvent, dimethylbenzene or its mixture, and under about 60 ℃ to about 75 ℃, the mixture of difference heating-type (II) compound and phenyl trichloromethyl mercury or phenyl trisbromomethyl mercury.
The third method under about room temperature, in the presence of acid chloride (II), is handled formula (II) compound in suitable solvent typically with the diethyl ether solution of diazomethane, obtain wherein R 2And R 4Both are formula (I) compound of hydrogen.
Another kind prepares wherein R 2And R 4The different methods that both are formula (I) compound of hydrogen is, not having to form the pyrazoline intermediate with aforesaid method in the presence of the acid chloride (II), subsequently under about 135 ℃ to about 145 ℃, in the preferred dimethylbenzene of suitable solvent, isolated pyrazoline is carried out thermolysis, make required compound.
Formula (II) compound can be made by following formula (III) compound:
Figure A9718033400141
Wherein X is a bromine or iodine, and R 1, R 3And R 5As definition in the above-mentioned formula (II), condition is R 5It can not be bromine or iodine.Preferably, X is an iodine.In solvent suitable, the degassing arbitrarily,, formula (III) compound and the vinylation reagent that suits to realize conversion by being carried out transition metal-catalyzed cross coupling (cross-coupling) reaction.Preferably, described transition metal is that palladium and described vinylation reagent are organic tin derivates.For example, in the presence of four (triphenyl phosphine) palladium (O), under about 80 ℃, in dimethyl formamide, formula (III) compound with the processing of three normal-butyls (vinyl) tin, is obtained wherein R in room temperature 7, R 6And R 8It is formula (II) compound of hydrogen.
In addition, R wherein 5Be hydrogen, C 1-C 4The formula of alkyl or halogen (II) compound can be with conventional witig reaction by obtaining humulus reactant salt in following formula V compound and the suitable alkane base phosphonium salt deutero-: R wherein 7Be hydrogen or the C that replaced arbitrarily by one or more halogens 1-C 4Alkyl, R 5Be hydrogen, C 1-C 4Alkyl or halogen, and R 1And R 3As definition in the above-mentioned formula (II).
For example, in suitable solvent, Jia base triphenyl phosphonium halogenide is handled with highly basic, added the formula V compound subsequently, can prepare wherein R 6And R 8Both are formula (II) compound of hydrogen.Preferably, described alkali reagent is the hexane solution of n-Butyl Lithium, and described solvent is ether or tetrahydrofuran (THF), and describedly is reflected at about room temperature and carries out under about 35 ℃.
For R wherein 7Be C 1-C 4Alkoxyl group, R 6And R 8Be hydrogen, R 5Be hydrogen, C 1-C 4Alkyl or halogen, and R 1And R 3Formula (II) compound as definition in the above-mentioned formula (II) particularly uses alkene change sequence usually, therefore in the presence of mercury (II) salt, at suitable C 1-C 4In the alkanol, incite somebody to action wherein R 7, R 6And R 8Be hydrogen, R 5Be hydrogen, C 1-C 4Alkyl or halogen, and R 1And R 3Formula (II) compound iodinate as definition in the above-mentioned formula (II) obtains intermediate alpha-alkoxy base-β-iodine ethyl pyrazoles, at random in suitable solvent, with suitable alkali it is carried out dehydroiodination and reacts subsequently.For example, work as R 7When being methoxyl group, the first step reaction is under the reflux temperature of about reaction medium, carry out with red precipitate and iodine in methyl alcohol, and the reaction of second step can be under about room temperature, with tertiary amine for example 1,8-diazabicylo [5.4.0] 11 carbon-7-alkene (DBU) carries out in toluene.
R wherein 5Formula (III) compound that is hydrogen or halogen can be by R wherein 5Be that amino formula (III) compound obtains by deaminizatingization or deaminizatingization-halogenation method respectively.Work as R 5When being hydrogen, conventional method is included in about room temperature under about 70 ℃, in the tetrahydrofuran (THF) as solvent, handles described amine with the nitrous acid tertiary butyl ester.For example, work as R 5When being chlorine, can under about 0 ℃,, subsequently described reaction mixture be heated under reflux temperature for example dichloromethane solution processing of acetonitrile solution usefulness nitrosyl chloride of suitable solvent of described amine.
According to similar methods, R wherein 5The formula V compound that is hydrogen or halogen can be by R wherein 5Be that amino formula V compound obtains.The latter can be by conventional acylation by R wherein 5Be amino and R 1And R 3Formula (IV) compound as definition in the above-mentioned formula (III) obtains.
R wherein 5Be C 1-C 4Alkyl or amino formula (III) compound also can be obtained by following formula (IV) compound by conventional bromination or iodate method:
Figure A9718033400161
R wherein 5Be C 1-C 4Alkyl or amino and R 1And R 3As definition in the above-mentioned formula (III).For example, when X is iodine, for example in the acetonitrile, handle formula (IV) compound in suitable solvent under about 85 ℃ with N-iodosuccinimide in about room temperature.
R wherein 7The formula V compound that is hydrogen usually can be with the oxygenizement of various ordinary method by vinyl by R wherein 7, R 6And R 8Be hydrogen, R 5Be hydrogen, C 1-C 4Alkyl or halogen, and R 1And R 3Formula (II) compound as definition in the above-mentioned formula (II) makes.For example, wherein a kind of these class methods comprise, in the presence of 4-methylmorpholine-N-oxide compound, in suitable solvent, handle described alkene with perosmic anhydride, handle described reaction mixture with sodium metaperiodate subsequently.Preferably, described perosmic anhydride adds with the form of t-butanol solution, and reaction solvent is 90% aqueous acetone solution, and described being reflected under about room temperature carried out.
Obviously, similarly be also can make wherein R by corresponding alkene with this method for oxidation 7By any C that replaces of one or more halogens 1-C 4The formula V compound of alkyl.Yet, work as R 7When being methyl, the another kind of method for preparing the formula V compound is that following formula (VI) compound is carried out hydration:
Figure A9718033400162
R wherein 8Be hydrogen, and R 1, R 3And R 5As defining in the above-mentioned formula V.More advantageously, this method also can be used for R 5It is amino situation.
Like this, under about room temperature, in the suitable solvent, can obtain corresponding 4-acetyl pyrazole derivative with acid treatment alkynes (VI).Preferably, described acid is tosic acid, and described solvent is an acetonitrile.
Formula (VI) compound itself can be by the precursor compound of suitable protection R wherein for example 8Formula (VI) compound that is trimethyl silyl obtains.At this moment, in suitable solvent for example in the methyl alcohol, with weak base for example salt of wormwood can finish deprotection reaction.
Usually, work as R 5When being not bromine or iodine, described protected alkynes can be obtained by formula (III) compound by the transition metal-catalyzed crosslinked coupled reaction with trimethyl silyl acetylene in suitable solvent in the presence of excessive tertiary base.Preferably, described transition metal is a palladium.For example, in the presence of two (triphenyl phosphine)-Palladous chlorides (II), cuprous iodide and triethylamine, about 45 ℃ to about 65 ℃ of dimethyl formamides, handle formula (III) compound with trimethyl silyl acetylene.2. formula (I) compound also can be by another kind of Cyclopropanation process preparation, and wherein required carbene class material can be obtained by the precursor compound that contains pyrazoles in the presence of suitable alkene.The aryl sulfonyl hydrazone derivative that a kind of this type of precursor compound is following formula V compound, promptly following formula (VII) compound:
Figure A9718033400171
Wherein Ar is separately can be by C 1-C 4Alkyl, C 1-C 4The phenyl or naphthyl that alkoxy or halogen replaces arbitrarily, and R 1, R 3, R 5And R 7As defining in the above-mentioned formula V.Preferably, Ar is 4-aminomethyl phenyl (p-methylphenyl).
The formula of an alkali metal salt derivative form (VII) compound (lithium salts preferably, it can make an appointment with-78 ℃ to about room temperature, in suitable solvent, hexane solution with n-Butyl Lithium is obtained at an easy rate by formula (VII) compound) in the presence of transition-metal catalyst and following formula (VIII) alkene, at random at suitable solvent methylene dichloride and at random under pressure for example, carry out thermolysis R wherein 2, R 4, R 6And R 8As definition in the above-mentioned formula (I).Described reaction usually about room temperature to about 80 ℃ temperature with at about 101kPa (14.7psi) to about 2757kPa (400psi) pressure, usefulness excessive formula (VIII) compounds is in a large number carried out.Obviously, under elevated pressure, the applying pressure container is necessary (otherwise can explode), and this is a preferable methods for the more weak alkene of reactivity.Preferably, described transition metal is the suitable salt form of rhodium (II), for example rhodium acetate (II).
Typical method comprises that under about 50 ℃ to about 70 ℃, in anhydrous methylene chloride, (wherein Ar is 4-aminomethyl phenyl and R to heating-type (VII) compound 1, R 3, R 5And R 7As definition in the above-mentioned formula (VII)) the mixture of lithium salts, formula (VIII) compound and rhodium acetate (II) dipolymer.
If no longer be described further, according to conventional handbook of organic chemistry or document formerly, by with the described similarity method of preparation example part or by conventional synthetic method, utilize suitable reagent and reaction conditions can obtain formula (IV) and (VII) intermediate by the raw material of easy acquisition.
In addition, but those skilled in the art will recognize that for the hereinafter embodiment of preparation formula (I) compound and the described method of preparation example part various variations can be arranged and can make change.
On certain same form (I) compound medicine, the animal doctor is last and agriculturely acceptable acid salt and also can prepare according to a conventional method.For example, in pure state or suitable solvent, with the suitable described free base solution of acid treatment, and by filtration or with the separating obtained salt of reaction solvent reduction vaporization.
Compound of the present invention, promptly formula (I) compound has parasiticidal effects to people, animal and plant.They are specially adapted to handle epizoon.
As for the application of compound of the present invention on the person, what can provide has:
Parasiticidal composition on a kind of medicine, said composition contains each pharmaceutically acceptable solvate and pharmaceutically acceptable diluent or carrier of formula (I) compound or its pharmaceutically acceptable salt or they, and said composition can be suitable for topical application;
Formula (I) compound or its pharmaceutically acceptable salt or they each pharmaceutically acceptable solvate or contain the pharmaceutical composition of above-mentioned each material, as medicine;
Formula (I) compound or its pharmaceutically acceptable salt or they each pharmaceutically acceptable solvate or contain the application of pharmaceutical composition in the medicine of preparation treatment parsitism of above-mentioned each material; With
A kind of method for the treatment of people's parsitism, this method comprise formula (I) compound with significant quantity or its pharmaceutically acceptable salt or they each pharmaceutically acceptable solvate or the pharmaceutical composition that contains above-mentioned each material described people is treated.
As for they application in the non-human animal, described compound can be used separately or to use with kind of concrete application, the specific host animal treated and the relevant suitable dosage form of parasite.The application process of described compound comprises Orally administered capsule, pill agent, tablet or drencs, topical application filling agent, some drops, preserved material, sprays, mousse, shampoo or pulvis, they can use or use with the implant form through injection (for example subcutaneous, intramuscular or intravenously) in addition.
According to the routine veterinary practice, this type of preparation can prepare with ordinary method.Described capsule, pill agent or tablet can by with described active ingredient with contain in addition disintegrating agent and/or tackiness agent for example the suitable meticulous diluent or carrier of starch, lactose, talcum or Magnesium Stearate etc. be mixed with.The oral veterinary draught can prepare by described active ingredient is dissolved in or is suspended in the appropriate medium.Filling agent and the some drops can by described active ingredient is dissolved at random added volatile components for example the pharmaceutically acceptable liquid vehicle of propan-2-ol for example prepare in butyl digol, whiteruss or the non-volatile ester.In addition, filling agent, some drops or sprays can be by preparing with the capsule sealing, to discharge remaining active agent on described animal surface.Injection can be prepared into and can contain the sterile solution form that other compositions for example are enough to make described solution and isoosmotic salt of blood or sucrose.Acceptable liquid vehicle comprises for example sesame oil of vegetables oil, glyceryl ester is vanay, the ester derivative of fatty acid of phenylformic acid benzyl ester, tetradecanoic acid isopropyl esters and propylene glycol for example for example, and organic solvent for example pyrrolidin-2-one and Sericosol N.Described preparation is by being dissolved in described active ingredient or being suspended in the described liquid vehicle so that final preparation contains the described active ingredient of 0.01-10% (weight ratio) prepares.
The amount of contained active compound can change according to the kind of the host animal of being treated, the severity of infection and type and described host's body weight in these preparations.For non-enteron aisle, part and Orally administered, the typical dosage range of described active ingredient is the described the weight of animals of 0.01-100mg/kg.Preferably, described scope is at 0.1-10mg/kg.
In addition, described compound can be used and can prepare spissated fodder additives or the premix mixture mixes with the intact animal feed for this reason with animal-feed.
Compound of the present invention can be used for controlling arthropod.Particularly, they can be used for field of veterinary, Poultry farming industry and protection publilc health: anti-vertebrates, particularly warm-blooded vertebrate comprises people and performing animal such as ox, sheep, goat, horse, pig, poultry, dog, interior or the epizoic arthropods of cat and fish body, for example mite comprises that (for example hard tick belongs to tick, Boophilus such as boophilus microplus, Amblyomma, Hyalomma, Rh such as Africa fan head belong to, Haemaphysalis, Dermacentor, Ornithodoros (for example tampan tick genus), (for example Damalinia belongs to mite, Dermanyssus gallinae, itch mite belongs to for example itch mite, Psoroptes, Chorioptes, Demodex, Eutrombicula); Diptera (for example Aedes, Anopheles, Nuscidae for example tatukira and Haematobia irritans, Hypoderma, Gasterophilus, Simulium); Hemiptera (for example Triatoma); Anoplura (for example Damalinia genus, Linognathus); Siphonaptera (for example Ct); Dictyoptera (for example Periplaneta, Blatella belong to) and Hymenoptera (for example little red ant); Be used for protection store product for example cereal grass comprise grain and flour, Semen arachidis hypogaeae, animal-derived food product, timber and family expenses goods for example carpet and textiles, the invasion and attack of anti-following biology, described biology is an arthropods, particularly beetle comprises weevil, moth and mite, and for example meal moth belongs to (flour moth), Anthrenus (carpet beetle), Tribolium (flour beetle), Sitophilus (grain weevil) and mite and belongs to (mite); Be used for controlling cockroach, ant and the termite and the similar arthropod that parasitize poultry and industrial house; Be used for controlling the mosquito larvae of water route, well, reservoir or other flowing water and hydrostatic; Be used for Ground Treatment, building and soil to prevent the invasion and attack of termite to building, for example Reticulitermes, different Cryptotermes, Coptotermes formosanus Shtrari belong to; Be used for agricultural and go up anti-lepidopteran (butterfly and moth) adult, larva and ovum, for example genus heliothis such as Heliothis virescens (tobacco budworm), bollworm (Heliothis armioera and Heliothis zea), prodenia litura belongs to as african armyworm, S.littoralis (Egyptian prodenia litura), subtropics mythimna separata (southern mythimna separata), tippet mythimna separata (tippet mythimna separata), the real moth (earias insulana) of Earias such as cotton spot, Pectinophora spp such as pink bollworm (pink bollworm), snout moth's larva belongs to for example Pyrausta nubilalis (Hubern). (European corn borer), cabbage looper (cabbage looper), Pier (Pier), Noctua (mythimna separata), Agrotis (Agrotis and Amathes) (cutworm), Wiseana belongs to (porina), straw borer spp (rice-stem borer), yellow rice borer belongs to and different crambid belongs to (sugarcane moth borer and the snout moth's larva of rice), pilleriana (grape steinernema), the moth-eaten moth (carpocapsa pononella) of apple, Archips spp (the brown Acleris spp of apple), small cabbage moth (small cabbage moth); Be used for anti-Coleoptera (beetle) adult and larva, for example brown bark beetle (coffee berry bark beetle), bark beetle Eimeria (bark beetles), Anthonomusgrandis (anthonomus grandis), Acalymma belongs to (aulacophora femoralis), scotellaris belongs to, phyllotreta, horse bell administration beetle (horse bell administration beetle), the chrysomelid genus of bar (pumpkin 12 asterophyllite first), the soil Eimeria (European sand dive worm) of diving, click beetle belongs to (cutworm), Dermolepida and xylotrupes dichotomus belong to (Qi increases), horseradish daikon leaf beetle (horseradish daikon leaf beetle), american rice weevil (Lissorhoptrus oryzophilus Kuschel), Melioethes belongs to (pollen beetle), the goitre weevil belongs to, weevil belongs to and root weevil belongs to (root weevil); Be used for for example leaf lice genus of anti-Hemiptera, Aleyrodes, Aphis, knurl volume Aphis, broad bean is repaiied the tail aphid, Phylloxera spp, adelgid belongs to, hops wart volume aphid (hops wart volume aphid), Aeneolamia belongs to, rice green leafhopper belongs to (nephotettix bipunctatus), Empoasca spp belongs to, brown paddy plant hopper belongs to, plant hopper belongs to, plant hopper belongs to, circle helmet a red-spotted lizard belongs to (red round a red-spotted lizard), fat fat Eimeria, false fat fat Eimeria, fleahopper belongs to (by the tree fleahopper), fleahopper belongs to (Lygusspp), red stinkbug belongs to, chinch bug belongs to, Bemisia spp, Nymenoptera is tenthredinidae and stem honeybee genus (sawfly) for example, leaf cutting ant belongs to (leaf cutting ant), Diptera is Hylemyia (root flies) for example, the awns horn fly belongs to and Hippelates (shoot flies), Liriomyza belongs to (Gracilariidae), Anastrepha (fruit bat), Thysanoptera is cotton thrips for example, for example migratory locusts belong to Orthoptera and grasshopper belongs to (locust) and cricket for example oily calabash genus and cricket spp, Collembola is Entomobrya (Sminthurus spp and Onychiurusspp) (springtail) for example, Isoptera is Cryptotermes (termite) for example, Dermaptera for example ball Sou belong to (earwig) and can be used for anti-other agriculturals go up important arthropodss for example mite (mite) belong to as tetranychus telarius, Panonychus citri belongs to and Bryobia (tetranychid), Eriophyes (goitre mite), Polyphacotarsonemus belongs to, Blaniulus belongs to (thousand-legger), common house centipede belongs to (common house centipede), tide Eimeria (woodlice) and apus belong to (Crustachia).
Compound of the present invention also can be used for the arthropod in the controlling plant.Described active compound is administered to the position that arthropods infects usually, and with the ratio of the about 0.005kg in per hectare pre-treatment position to about 25kg active compound, preferred 0.02-2kg/ha controls.Under ideal conditions, according to the insect that remains to be prevented and treated, provide suitable protection with lower ratio.On the other hand, disadvantageous weather condition and other factors may need to use the active ingredient of higher proportion.When to foliage applying, spendable ratio is 0.01-1kg/ha.
When described insect survived in soil, the preparation that contains described active compound can intersperse among handled zone equably with any ordinary method.If desired, usually can be to field or the dispenser of plant growth district, perhaps to leaning on very tightly local dispenser with protected seed of avoiding attacking or plant.Described active ingredient can spray that described zone is scrubbed in the soil or can be by the natural rainfall effect by water.During the dispenser or after the dispenser, if desired, described preparation can mechanically intersperse among in the soil, for example by ploughing or rake the soil level.Dispenser can be before plantation, in the plantation, after the plantation, but should occur in sprout preceding or sprout after.
Compound of the present invention is more valuable to be to prevent and treat the insect of the position of alimentary crop away from dispenser point, for example can kill the insect of edible leaf by use described purpose compound to root.In addition, described compound can prevent that also the method that eats or Repellent effect reduce the infringement to described crop.
It is the protection field that compound of the present invention is worth the place especially; army provisions; the plantation circle; the greenhouse; orchard and vineyard crop; perhaps circle and forest-tree are planted in ornamental plant and protection; for example cereal grass is (as corn; wheat; paddy rice; Chinese sorghum); cotton; tobacco; vegetables and salad (soya bean for example; the Btassica farm crop; cucurbit; lettuce; onion; tomato and pepper); field crops (is affixed one's name to as the horse bell; beet; peanut; soybean; the Semen Brassicae campestris rape); sugarcane; grassland and army provisions are (as corn; Chinese sorghum; clover); the plantation circle is (as tea; coffee; cocoa; banana; plam oil; coconut; rubber; essence); orchard and hurst are (as drupe and kernel fruit; citrus; Kiwifruit; avocado; mango; olive and English walnut); the vineyard crop; ornamental plant; fresh flower in the greenhouse, park and shrub, and in the forest zone; hurst (comprising two kinds of deciduous plant and evergreen plants) in plantation circle and the nursery.
Their value also is to protect timber (placement, that cut down, transportation, standby with architectural) to prevent by sawfly (for example Scolytidae, Platypodidae, Lyctidae, Bostrichidae, Cerambycidae, Anobiidae), beetle (for example) or termite (belonging to as Reticulitermes, different Cryptotermes, Coptotermes formosanus Shtrari) invasion and attack.
In addition, they also can be used for protecting and store product such as grain, fruit, nut, spices and tobacco, grind or be mixed into the no matter any infringement of avoiding moth, beetle and mite in the product.The infringement that also can protect the animal product of storage for example natural skin, hair, wool and feather or reformulations (for example carpet or textiles) to avoid moth and beetle, meat and fish avoid the infringement of beetle, mite and fly.
The value of compound of the present invention also is to control to people and domestic animal injury or pathophoresis or as the arthropods of Disease carrier, arthropods for example mentioned above, and particularly control tick, mite, lice, flea, midge and sting, disagreeable and fly that can bring myiosis.Particularly they are present in the domestic animal body or the arthropods of looking for food or sucking animal blood in skin surface and skin applicable to control, and they can be by oral, non-enteron aisle, subcutaneous or topical application for this reason.
Therefore, the present invention provides a kind of animal doctor or Agrotechnical formulation on the other hand, and said preparation contains that formula (I) compound or its animal doctor go up or agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing and the animal doctor goes up or agricultural goes up acceptable diluent or carrier.Preferably, described preparation is suitable for topical application.
The present invention further provides that formula (I) compound or its animal doctor go up or animal doctor that agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing or contains above-mentioned each material goes up or agricultural goes up acceptable preparation as the Parasiticidal medicine.
The present invention also provides a kind of method of punishing the parsitism of certain position, and this method comprises that formula (I) compound with significant quantity or its animal doctor go up or agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing or the animal doctor of containing above-mentioned each material goes up or agricultural goes up acceptable preparation described position is punished.
Preferably, described position is skin or the fur of animal, the soil around the perhaps plant surface, or the plant of being punished.
Be understandable that the punishment of indication here comprises prevention and alleviates and/or cure the symptom that parsitism occurs.Kill the insect active test
Gather and grow up fly (tatukira) and use CO 2Anesthesia.Thoracic cavity and careful place that the acetone soln (1 μ l) that will contain described test compound is applied directly to each fly are placed in the 50ml test tube that covers with damp gauze, to reclaim CO 2Negative contrast is that acetone (1 μ l) is administered to them.Administration was evaluated mortality ratio after 24 hours.Table 1 has been illustrated the external activity of the anti-tatukira that grows up of selected The compounds of this invention.Obtaining 100% mortality ratio required dosage in the end represents with a μ g/ fly in the hurdle.
Table 1
Embodiment number A μ g/ fly
????3A ????0.05
????7 ????0.05
????19 ????0.05
????27 ????0.05
????47 ????0.05
The acaricidal activity test
The suitable solvent of getting the described test compound of 0.5ml 1mg/ml equably with valinche is acetone or alcohol solution for example, with 10 μ g/cm 2Dosage to be added to that size cuts be on WhatmanNo.1 (trade mark) filter paper of 8 * 6.25cm.After the drying,, with the sealing of two limits and place the Kilner bottle that contains with the cotton-wool of water-wet, placed 24 hours down with described bottle sealing and in 25 ℃ then with hemming device with described filter paper doubling.Afterwards, 50 boophilus microplus larvas are joined in the treated paper bag,, reach sealing fully then along the sealing of limit, the 3rd road.Paper bag is put back in the Kilner bottle again, placed again 48 hours with its sealing and under 25 ℃.Take out paper bag then and assess mortality ratio.Obtain negative contrast by only being cut into the filter paper of suitable size and handling by the same way with the 0.5ml solvent treatment.Can obtain active result under other dosage by the concentration that changes testing liquid.
Table 2 has been illustrated the external activity of the anti-boophilus microplus larva of selected The compounds of this invention.Obtain 100% mortality ratio required dosage in the end in the hurdle with μ g/cm 2Expression.
Table 2
Embodiment number ??μg/cm 2
????3A ????0.50
????7 ????0.50
????19 ????0.50
????47 ????1.00
Compound of the present invention and be used for the synthetic of intermediate of the present invention and illustrate by the following example and preparation example.
Fusing point is measured with uncorrected Gallenkamp fusing point instrument.
Nucleus magnetic resonance (NMR) data obtain with Bruker AC300 or AM300 spectrograph, and (δ) is consistent with the structure of being advised in the chemical shift of being measured.
Mass spectrum (MS) data obtain with Finnigan Mat.TSQ 7000 or Fisons InstrumentsTrio 1000 spectrographs.The calculating of being quoted and the ion of actual measurement are meant the isotopic composition of minimum mass.
HPLC is meant high performance liquid chromatography.
Room temperature is meant 20-25 ℃.
Embodiment 15-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Under vigorous stirring, with the mixture reflux of preparation example 2 described title compounds (1.0g), bromofom (13ml), benzyltriethylammoinium chloride (0.075g), 60% aqueous sodium hydroxide solution (2ml), methylene dichloride (12ml) and ethanol (0.5ml) 10 days, make its cooling and dilute with water then.Isolating organic phase is joined in silica gel (10g) post and uses the methylene dichloride wash-out.Will by gained crude product in the suitable stream part on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (50: 40: 10) is made eluent, obtains the described title compound of pale solid shape, m.p.178-179 ℃. δ (CDCl 3): 2.28 (d, 2H), 2.61
(t, 1H), 3.80 (br.s, 2H), 7.8 (s, 2H) .MS (thermal spray): M/Z[M+H] 516.4;
C 14H 7Br 2Cl 2F 3N 4+ H theoretical value 516.84.
Embodiment 2 3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Ethanol (0.1ml) and sodium hydroxide (0.29g) water (0.5ml) solution are joined in methylene dichloride (2ml) solution of preparation example 4 described title compounds (0.6g) under stirring and bromofom (1.83g), add benzyltriethylammoinium chloride (0.01g) subsequently.Continuously compound of reaction was stirred under room temperature 18 hours, stirred 5 hours down, stirred 48 hours under the room temperature in 50 ℃, 50 ℃ stirred 4 hours down and room temperature under stirred partition between methylene dichloride (100ml) and water (100ml) then 18 hours.Separate organic phase, dry (MgSO 4) and reduction vaporization, obtain an oily matter, it is gone up through the column chromatography purifying in silica gel (10g), use hexane: methylene dichloride (3: 7) is made eluent, with products therefrom crystallization in hexane, obtain the described title compound of white solid, m.p.121-123 ℃ subsequently. δ (CDCl 3): 2.02 (t, 1H), 2.34 (dd, 1H), 2.88 (dd, 1H), 7.53 (s, 1H), 7.78 (s, 2H) .MS
(thermal spray): M/Z[M+NH 4] 518.9; C 14H 6Br 2Cl 2F 3N 3+ NH 4Theoretical value 518.86.
Embodiment 3A and 3BA. (-)-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles and B. (+)-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
(25cm * 2cm) through chirality HPLC fractionation embodiment 2 described title compounds (28.5mg), use hexane: propan-2-ol (93: 7) is made eluent, and the eluent flow velocity is the 9ml/ branch with Chirapak (trade mark) AD post.
At first wash-out obtain and that obtain with the white crystalline solid form is (-)-enantiomorph (A), m.p.132.5-135 ℃.
[α] D 25-42.54 ° (c=1.5mg/ml, methyl alcohol).
That second wash-out obtains and that obtain with the white crystalline solid form is (+)-enantiomorph (B), m.p.132.5-134 ℃ of .[α] D 25+ 44.02 ° (c=3.5mg/ml, methyl alcohol). measure through the crystal analysis of X-ray, a kind of enantiomorph in back is the R-configuration.
Embodiment 43-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Benzyltriethylammoinium chloride (0.01g) and ethanol (0.015ml) are joined in chloroform (0.66ml) solution of the preparation example 4 described title compounds (0.46g) under stirring, add 50% aqueous sodium hydroxide solution (0.25ml) then and reaction mixture is descended stirring 1 month in 60 ℃.With gained mixture partition between methylene dichloride and water, separate organic phase then, dry (MgSO 4) and reduction vaporization.Gained brown jelly is gone up through the column chromatography purifying in silica gel (10g), is made eluent with methylene dichloride, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (50: 40: 10) is made eluent.Products therefrom is crystallization in hexane, obtains the described title compound of colourless dish shape, m.p.123-126 ℃. δ (CDCl 3): 1.84 (t, 1H), 2.20 (dd, 1H), 2.85 (dd, 1H), 7.53 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 430.6; C 14H 6Cl 4F 3N 3+ NH 4Theoretical value 430.96.
Embodiment 55-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles
Add bromine (6.4ml) in methylene dichloride (2ml) solution of the preparation example 6 described title compounds (0.35g) under stirring, add ethanol (0.1ml) and sodium hydroxide (0.29g) water (0.5ml) solution subsequently, add benzyltriethylammoinium chloride (0.01g) then and reaction mixture was stirred 13 days down in 50 ℃, make its cooling.With gained mixture reduction vaporization and with resistates partition between methylene dichloride and water.Separate organic phase and merge with the acetic acid ethyl acetate extract of water, then with the organic solution salt water washing that merges, dry also reduction vaporization.Resistates on silica gel through the column chromatography purifying, make eluent with methylene dichloride, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (60: 30: 1 0) is made eluent, obtain the described title compound of white solid, m.p.178-180 ℃. δ (CDCl 3): 2.29 (d, 2H), 2.60 (t, H), 3.89 (br, s, 2H), 7.93 (d, 2H), MS (thermal spray): M/Z[M+H] 574.7; C 13H 7Br 2Cl 2F 5N 4S+H theoretical value 574.81.
Embodiment 63-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles
Except use hexane in the column chromatography purification step of beginning: methylene dichloride (1: 1) is done the eluent, according to embodiment 5 described similarity methods, obtains white foam shape thing by preparation example 8 described title compounds.δ (CDCl 3): 2.01 (t, 1H), 2.34 (dd, 1H), 2.88 (dd, 1H), 7.54 (s, 1H), 7.91 (d, 2H), MS (thermal spray): M/Z[M+NH 4] 576.8; C 13H 6Br 2Cl 2F 5N 3S+NH 4Theoretical value 576.83.
Embodiment 73-cyano group-4-cyclopropyl-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
In 25 minutes, ether (25ml) solution of 0.2M diazomethane joined in preparation example 4 described title compounds (0.332g) under stirring and acid chloride (II) ether (10ml) solution (0.01g) and with mixture under room temperature, stirred 18 hours.Reaction mixture (0.01g) is handled with other diazomethane diethyl ether solution (25ml) and acid chloride (II), stirred 24 hours, (0.01g) further handle restir 24 hours, reduction vaporization then with diazomethane diethyl ether solution (50ml) and acid chloride (II).Resistates is gone up through the column chromatography purifying in silica gel (5g), make eluent with methylene dichloride, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (50: 45: 5) is made eluent, obtain the described title compound of white solid, m.p.124 ℃. δ (CDCl 3): 0.77 (m, 2H), 1.07 (m, 2H), 1.89 (m, 1H), 7.29 (s, 1H), 7.74
(s, 2H) .MS (thermal spray): M/Z[M+NH 4] 362.8; C 14H 8Cl 2F 3N 3+ NH 4Theoretical value
363.04.
Embodiment 83-cyano group-4-(2,2-two bromo-3,3-dimethyl cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Toluene (2ml) solution of preparation example 10 described title compounds (0.15g) and phenyl trisbromomethyl mercury (0.44g) was heated 5 hours down in 70 ℃, make its cooling and reduction vaporization.Resistates through the reversed-phase HPLC purifying, is used acetonitrile on C18 silica gel: water: methyl alcohol (60: 30: 10) is made eluent, obtains the described title compound of pale solid shape, m.p.146-148 ℃. δ (CDCl 3): 1.31 (s, 3H), 1.70 (s, 3H), 2.52 (s, 1H), 7.78 (s, 2H), 7.79 (s, 1H), MS (thermal spray): M/Z[M+NH 4] 546.7; C 16H 10Br 2Cl 2F 3N 3+ NH 4Theoretical value 546.89.
Embodiment 93-cyano group-4-(2,2-two bromo-1-methyl cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Except the reaction times is 4 hours, subsequently reaction mixture is filtered and the silica gel chromatography step hexane of beginning: methylene dichloride (1: 1) is done outside the eluent, obtain a white solid, m.p.133-134 ℃ according to embodiment 8 described similarity methods by preparation example 15 described title compounds. δ (CDCl 3): 1.83 (s, 3H), 1.92 (d, 1H), 2.28 (d, 1H), 7.59 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 533.0; C 15H 8Br 2Cl 2F 3N 3+ NH 4Theoretical value 532.88.
Embodiment 103-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-methyl cyclopropyl) pyrazoles
Divide two parts to join to stir in preparation example 15 described title compounds (0.346g) down and acid chloride (II) ether (10ml) solution (0.01g) and and under room temperature, stirred filtration then 48 hours ether (20ml) solution of 0.007 M diazomethane with mixture.Reaction mixture (0.01g) is handled with other diazomethane diethyl ether solution (20ml) and acid chloride (II), stirred 24 hours and filtered, repeat this circulation then.What described reaction mixes and (0.01g) further handles with diazomethane diethyl ether solution (20ml) and acid chloride (II), stirs 5 days, filters and reduction vaporization.Resistates is crystallization in hexanaphthene, obtains the described title compound of yellow solid shape, m.p.138-139 ℃. δ (CDCl 3): 0.86 (m, 2H), 1.04 (m, 2H), 1.50 (s, 3H), 7.41 (s, 1H), 7.74
(s, 2H) .MS (thermal spray): M/Z[M+H] 359.8; C 15H 10Cl 2F 3N 3+ H theoretical value 360.03.
Embodiment 113-cyano group-4-(2,2-two bromo-1-methoxyl group cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Toluene (1ml) solution of preparation example 17 described title compounds (0.4g) and phenyl trisbromomethyl mercury (0.76g) was heated 4 hours down in 60 ℃, make its cooling and reduction vaporization.Resistates through the column chromatography purifying, is used hexane on silica gel: methylene dichloride (1: 1) is made eluent, obtains the described title compound of white solid, m.p.117-118 ℃. δ (CDCl 3): 2.22 (d, 1H), 2.40 (d, 1H), 3.43 (s, 3H), 7.80 (s, 2H), 7.84
(s, 1H) .MS (thermal spray): M/Z[M+H] 532.1; C 15H 8Br 2Cl 2F 3N 3The O+H theoretical value
531.84.
Embodiment 123-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(2,2,3,3-tetramethyl-ring propyl group) pyrazoles
With preparation example 18 described title compounds (0.04g), 2, methylene dichloride (0.3ml) solution of 3-dimethyl but-2-ene (1.08ml) and rhodium acetate (0.001g) dipolymer heated 30 minutes down and kept under this temperature 30 minutes again in 70 ℃.In reaction mixture, add methylene dichloride (0.3ml), with its reheat 1 hour, make its cooling and partition between methylene dichloride (5ml) and water (2ml) then.Separate organic phase, dry (MgSO 4) and reduction vaporization, resistates is gone up through the column chromatography purifying in silica gel (1g), makes eluent with methylene dichloride, obtains the described title compound of white crystalline solid shape,
M.p.158-159 ℃. δ (CDCl 3): 1.05 (s, 6H), 1.33 (s, 6H), 1.55 (s, 1H), 7.38 (s, 1H), 7.75 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 419.6; C 18H 16Cl 2F 3N 3+ NH 4Theoretical value 419.1.
Embodiment 133-cyano group-4-(t-2, t-3-two chloro-r-1-cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Anhydrous methylene chloride (7.5ml) solution of preparation example 18 described title compounds (0.254g), suitable-1,2-dichloroethene (7.0g) and rhodium acetate dipolymer (0.045g) was heated 4.5 hours down in 60 ℃, make it under room temperature, leave standstill then 18 hours.The gained mixture is gone up through the column chromatography purifying in silica gel (50g), makes eluent with methylene dichloride, obtains the described title compound of white crystalline solid shape, m.p.138-139 ℃. δ (CDCl 3): 2.80 (t, 1H), 3.80 (d, 2H), 7.75 (s, 1H), 7.80 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 431.3; C 14H 6Cl 4F 3N 3+ NH 4Theoretical value 430.96.
Embodiment 143-cyano group-4-(t-2, t-3-two bromo-r-1-cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Except with reaction mixture in 55 ℃ down heating 4 hours and in the trimethyl carbinol with the lyophilize of chromatographic purification step gained resistates, according to embodiment 13 described similarity methods, by preparation example 18 described title compounds and 1, the 2-sym-dibromoethane obtains a dark yellow solid, m.p.106-108 ℃. δ (CDCl 3): 2.76 (t, 1H), 3.80 (d, 2H), 7.78 (s, 2H), 7.80 (s, 1H) .MS (thermal spray): M/Z[M+H] 502.0; C 14H 6Br 2Cl 4F 3N 3+ H theoretical value 501.83.
Embodiment 153-cyano group-4-(two the ring [3.1.0] oneself-the 6-yl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Except compound of reaction is heated 4 hours down in 55 ℃, according to embodiment 13 described similarity methods, obtain a white solid by preparation example 18 described title compounds and cyclopentenes,
M.p.105-106 ℃. δ (CDCl 3): 1.41-2.06 (m, 9H), 7.47 (s, 1H), 7.75 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 403.4; C 17H 12Cl 2F 3N 3+ NH 4Theoretical value 403.07.
Embodiment 163-cyano group-4-(two the ring [4.1.0] heptan-the 7-yl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
According to embodiment 15 described similarity methods, obtain a white solid, m.p.113-114 ℃ by preparation example 18 described title compounds and tetrahydrobenzene. δ (CDCl 3): 0.87 (m, 2H), 1.21 (m, 2H), 1.46 (m, 2H), 1.59 (m, 2H), 1.78 (t, 1H), 2.04 (m, 2H), 7.52 (s, 1H), 7.77 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 417.0; C 18H 14Cl 2F 3N 3+ NH 4Theoretical value 417.09.
Embodiment 173-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(2,2-dimethyl cyclopropyl) pyrazoles
Preparation example 18 described title compounds (0.507g) and rhodium acetate (II) anhydrous methylene chloride (7ml) solution (0.045g) are joined in the lass lining bottle (volume 50ml), use twice of nitrogen wash then.In reaction vessel, add the 2-methacrylic and with reaction mixture in 55 ℃ of heating 2 hours down, ordering in room temperature then, it left standstill 18 hours.The gained mixture is gone up through the column chromatography purifying in silica gel (50g), makes eluent with methylene dichloride, obtains the very light described title compound of yellow solid shape, m.p.122-123 ℃. δ (CDCl 3): 0.70 (m, 1H), 0.96 (s, 3H), 1.00 (m, 1H), 1.26 (s, 3H), 1.74 (m, 1H), 7.25 (s, 1H), 7.76 (s, 2H), MS (thermal spray): M/Z[M+NH 4] 390.7; C 16H 12Cl 2F 3N 3+ NH 4Theoretical value 391.07.
Embodiment 183-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(spiral shell [2.4] heptan-1-yl) pyrazoles
Except reaction mixture was only heated 3 hours, according to embodiment 15 described similarity methods, obtain a faint yellow solid by preparation example 18 described title compounds and methylene radical pentamethylene, m.p.117-118 ℃, δ (CDCl 3): 0.88 (t, 1H), 1.22 (dd, 1H), 1.37 (m, 2H), 1.74 (m, 6H), 1.92 (dd, 1H), 7.27 (s, 1H), 7.74 (s, 2H), MS (thermal spray): M/Z[M+NH 4] 417.1; C 18H 14Cl 2F 3N 3+ NH 4Theoretical value 417.09.
Embodiment 193-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(2,2-difluoro cyclopropyl) pyrazoles
Except with reaction mixture in 50 ℃ and 2068kPa (300psi) heating 24 hours down, according to embodiment 17 described similarity methods, obtain by preparation example 18 described title compounds and vinylidene fluoride.Described product is further purified through reversed-phase HPLC on C18 silica gel, uses acetonitrile: water (55: 45) is made solvent, obtains the described title compound of white amorphous solid shape, δ (CDCl 3): 1.58 (m, 1H), 2.16 (m, 1H), 2.76 (m, 1H), 7.50 (s, 1H), 7.78 (s, 2H), MS (APCl): M/Z [M+H] 382.0; C1 4H 6Cl 2F 5N 3+ H theoretical value 381.99.
Embodiment 203-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(spiral shell [2,3] heptan-1-yl) pyrazoles
Except with reaction mixture in refluxing heating 4 hours down and omitting under subsequently the room temperature the standing over night step, according to embodiment 15 described similarity methods, obtain by preparation example 18 described title compounds and methylene radical tetramethylene, obtain the described title compound of white solid, m.p.108-110 ℃. δ (CDCl 3): 0.79 (m, 1H), 1.24 (m, 1H), 1.86-2.39 (m, 7H), 7.08 (s, 1H), 7.76 (s, 2H) .MS (thermal spray): M/Z [M+NH 4] 403.0; C 17H 12Cl 2F 3N 3+ NH 4Theoretical value 403.07.
Embodiment 213-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(spiral shell [2.2] penta-2-yls) pyrazoles
In the heavy wall Glass Containers of a sealing, anhydrous methylene chloride (7ml) solution with preparation example 18 described title compounds (0.507g), methylene radical cyclopropane (5ml) and rhodium acetate (II) dipolymer (0.045g) under stirring heated 24 hours down in 55 ℃, made its cooling then.As described in the embodiment 13 with the gained purifying mixture, obtain the described title compound of white solid, m.p.108-110 ℃. δ (CDCl 3): 0.81 (m, 1H), 0.91 (m, 1H), 0.99-1.18 (m, 3H), 1.66 (dd, 1H), 2.21 (dd, 1H), 7.29 (s, 1H), 7.74 (s, 2H), MS (thermal spray): M/Z[M+NH 4] 389.1; C 16H 10Cl 2F 3N 3+ NH 4Theoretical value 389.05.
Embodiment 224-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-methylpyrazole
Add bromofom (1.08ml) in methylene dichloride (4ml) solution of the preparation example 22 described title compounds (0.993g) under stirring, add sodium hydroxide (0.495g) water (1ml) solution and ethanol (0.1ml) subsequently, add benzyltriethylammoinium chloride (0.222g) then and reaction mixture is descended heating 6 days in 50 ℃.Add chloroform, aqueous sodium hydroxide solution and the ethanol of same amount again and continue stirring 5 days down in 50 ℃.With refrigerative reaction mixture partition between ether and water, water phase separated is also with ether (x2) extraction then.With the organic solution drying (Na that merges 2SO 4) and reduction vaporization, then with resistates on silica gel through the column chromatography purifying, use hexane: methylene dichloride (3: 2) is made eluent, with cold hexane development, obtains the described title compound of pale solid shape subsequently,
M.p.66.8-68.2 ℃. δ (CDCl 3): 1.87 (t, 1H), 2.19 (dd, 1H), 2.47 (s, 3H), 2.64 (dd, 1H), 7.22 (s, 1H), 7.80 (s, 2H), MS (thermal spray): M/Z[M+H] 491.0; C 14H 9Br 2Cl 2F 3N 2+ H theoretical value 490.85.
Embodiment 234-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3
Add bromofom (1.1ml) in methylene dichloride (2ml) solution of the preparation example 25 described title compounds (0.368g) under stirring, add sodium hydroxide (0.175g) water (0.5ml) solution and ethanol (0.1ml) subsequently, add then benzyltriethylammoinium chloride (0.01g) and will be under the reaction mixture refluxed heating 4 days.Add chloroform, aqueous sodium hydroxide solution and the ethanol of same amount again and continue stirring 9 days down in refluxing.With the refrigerative reaction mixture with methylene dichloride (20ml) dilution, this mixture successively water (3 * 15ml) and salt solution (10ml) washing, drying (MgSO 4) and reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (30g), use hexane, use hexane then: ether: methylene dichloride (8: 1: 1) is made eluent, goes up through the reversed-phase HPLC purifying in C18 subsequently, use acetonitrile: water: methyl alcohol (60: 30: 10) is made eluent, obtains the described title compound of an oily.δ (CDCl 3): 1.93 (t, 1H), 2.10 (s, 3H), 2.19 (dd, 1H), 2.36 (s, 3H), 2.60 (dd, 1H), 7.73 (s, 2H), MS (thermal spray): M/Z[M+H] 504.9; C 15H 11Br 2Cl 2F 3N 2+ H theoretical value 504.87.
Embodiment 244-(2,2-dibromo cyclopropyl)-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles
Join water (1ml) solution of sodium hydroxide (0.64g) and ethanol (0.1ml) in methylene dichloride (2ml) solution that stirs preparation example 28 described title compounds (1.0g), bromofom (2ml) and benzyltriethylammoinium chloride (0.04g) down and, make its cooling then heating 16 hours under the reaction mixture refluxed.With gained mixture partition between methylene dichloride and water, separate organic phase, water and salt water washing successively, dry (Na 2SO 4) and reduction vaporization.Resistates on silica gel through the column chromatography purifying, use hexane: ethyl acetate (50: 1) is made eluent, obtain a yellow oil, with similarity method it is further purified, use hexane: ethyl acetate (19: 1) is made eluent, with after the propan-2-ol development, obtains the described title compound of yellow solid shape subsequently, m.p.84-86 ℃, δ (CDCl 3): 1.79 (t, 1H), 2.19 (dd, 1H), 2.44 (s, 3H), 2.63 (dd, 1H), 7.18 (s, 1H), 7.44 (s, 2H), MS (thermal spray): M/Z[M+H] 456.8; C 13H 9Br 2Cl 3N 2+ H theoretical value 456.83.
Embodiment 254-(2,2-dichloro cyclopropyl)-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles
Join 50% aqueous sodium hydroxide solution (2ml) in the ethanol (0.2ml) that stirs preparation example 28 described title compounds (1.0g), chloroform (7ml) and benzyltriethylammoinium chloride (0.08g) down and methylene dichloride (2ml) mixture solution and will heat 16 hours under the reaction mixture refluxed.The chloroform (3ml), benzyltriethylammoinium chloride (0.04g) and the sodium hydroxide solution (1ml) that further add same amount stir reaction mixture 16 hours down in refluxing then, make its cooling and partition between methylene dichloride and water.Separate organic phase, water and salt water washing successively, dry (Na 2SO 4) and reduction vaporization.Resistates on silica gel through the column chromatography purifying, use hexane: ethyl acetate (19: 1) is made eluent, obtain a yellow oil, on C18 silica gel, it is further purified through reversed-phase HPLC, use acetonitrile: water: methyl alcohol (60: 30: 10) is made eluent, obtains the described title compound of colorless oil.δ (CDCl 3): 1.61 (t, 1H), 2.02 (dd, 1H), 2.42 (s, 3H), 2.63 (dd, 1H), 7.20 (s, 1H), 7.47 (s, 2H) .MS (thermal spray): M/Z[M+H] 368.8; C 13H 9Cl 5N 2+ H theoretical value 368.93.
Embodiment 26A and 26BA. 4-(c-2-bromo-r-1-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles and B. 4-(t-2-bromo-r-1-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Under-10 ℃, three-normal-butyl stannic hydride (0.9g) is added drop-wise in toluene (10ml) solution of the embodiment 2 described title compounds (0.504g) under stirring through syringe, make reaction mixture be warmed to room temperature, stirred 5 hours, kept 3 days down at-20 ℃, make it be warmed to room temperature once more, and then handle with three-normal-butyl stannic hydride (0.9g).With this mixture restir 24 hours, use water treatment, after 30 minutes, water phase separated is also used dichloromethane extraction.Dry and the reduction vaporization with the organic phase that merges, obtain a brown oil, with its on silica gel through the column chromatography purifying, use hexane: methylene dichloride (4: 1), make eluent with methylene dichloride then, with the crystallization in dipropyl-2-base ether of required product, obtain light pale solid shape isomer A, m.p.120.5-121 ℃ subsequently. δ (CDCl 3): 1.22 (m, 1H), 1.82 (m, 1H), 2.29 (m, 1H), 3.40 (m, 1H), 7.47 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 441.0; C 14H 7BrCl 2F 3N 3+ NH 4Theoretical value 440.95.
With crystalline mother solution on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (50: 40: 10) is made eluent, obtains light pale solid shape isomer B, m.p.126 ℃. δ (CDCl 3): 1.59 (m, 1H), 1.62 (m, 1H), 2.40 (m, 1H), 3.14 (m, 1H), 7.39 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 441.4; C 14H 7BrCl 2F 3N 3+ NH 4Theoretical value 440.95.
Embodiment 273-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles
Dimethylbenzene (250ml) solution of preparation example 31 described title compounds (27g) was heated 16 hours under gentle reflux, remove solvent then under reduced pressure.The gained resistates through the column chromatography purifying, is used hexane on silica gel, use hexane then: ether (8: 1) is made eluent, and crystallization in hexanaphthene subsequently obtains the described title compound of white solid, m.p.141 ℃. δ (CDCl 3) 1.24 (m, 2H), 1.52 (m, 2H), 7.72 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 431.3; C 15H 7Cl 2F 6N 3+ NH 4Theoretical value 431.0
Embodiment 285-chloro-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Add bromofom (0.275ml) in methylene dichloride (1ml) solution of the preparation example 33 described title compounds (0.288g) under stirring, add water (0.25ml) solution and the ethanol (0.05ml) of sodium hydroxide (0.126g) subsequently.Add benzyltriethylammoinium chloride (0.006g) and with reaction mixture vigorous stirring 48 hours under room temperature, 50 ℃ of heating 7 hours were down stirred 24 hours under room temperature then.Further heating is after 24 hours down in 50 ℃, and water (0.25ml) solution and the ethanol (0.05ml) that add bromofom (0.275ml), sodium hydroxide (0.126g) also continue to stir 72 hours.With the reaction mixture cooling, partition between ether and water, water phase separated is also used ether (x2) extraction.The extraction liquid salt water washing that merges, dry (Na 2SO 4) and reduction vaporization, then with resistates on silica gel through the column chromatography purifying, use hexane: methylene dichloride (3: 2) is made eluent, crystallization in hexane subsequently obtains the described title compound of white solid, m.p.103.5-104.2 ℃. δ (CDCl 3): 2.31 (dd, 1H), 2.42 (t, 1H), 2.78 (dd, 1H), 7.80 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 552.9; C 14H 5Br 2Cl 3F 3N 3+ NH 4Theoretical value 552.82.
Embodiment 294-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-trifluoromethyl pyrazol
Add bromofom (0.49ml) in methylene dichloride (3ml) solution of the preparation example 36 described title compounds (0.530g) under stirring, add water (1ml) solution and the ethanol (0.1ml) of sodium hydroxide (0.226g) subsequently.Add benzyltriethylammoinium chloride (0.01g) and reaction mixture is descended heating 3 days in 50 ℃.Add water (1ml) solution and the ethanol (0.1ml) of bromofom (0.49ml), sodium hydroxide (0.226g) and continue heating 5 days.With the reaction mixture cooling, partition between ether and water, water phase separated is also used ether (x2) extraction.The organic extract liquid salt water washing that merges, dry (Na 2SO 4) and reduction vaporization, then with resistates on silica gel through the column chromatography purifying, use hexane: ether: methylene dichloride (1: 1: 2) is made eluent, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (60: 30: 10) is made eluent, obtains the gluey described title compound of yellow-green colour.δ(CDCl 3)：1.87(t，1H)，2.28(dd，1H)，2.84(dd，1H)，7.40(s，1H)，7.82(s，2H).MS(thermospray)：M/Z[M+H]544.6；C 14H 6Br 2Cl 2F 6N 2+Hrequires?544.83.
Embodiment 304-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-phenylpyrazole
Add bromofom (1ml) in methylene dichloride (4ml) solution of the preparation example 40 described title compounds (0.3g) under stirring, add water (0.1ml) solution and the ethanol (0.1ml) of sodium hydroxide (0.125g) subsequently.Add benzyltriethylammoinium chloride (0.022g) and with reaction mixture in 50 ℃ of heating 5 days down, make its cooling and partition between methylene dichloride (10ml) and water (10ml).Separate organic phase, wash with water, dry (MgSO 4) and reduction vaporization, then resistates is gone up through the column chromatography purifying in silica gel (70g), use hexane: ether gradient liquid (100: 0-95: 5-90: 10-0: 100) wash-out, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (60: 30: 10) is made eluent.The required stream that the HPLC post is obtained part concentrates and (3 * 20ml) extract with methylene dichloride.With the combining extraction liquid lyophilize, obtain the described title compound of pale solid shape, 48 ℃. δ (CDCl 3): 1.86 (t, 1H), 2.22 (dd, 1H), 2.80 (dd, 1H), 7.35 (s, 1H), 7.40-7.60 (m, 3H), 7.75 (s, 2H), 7.92 (d, 2H) .MS (thermal spray): M/Z[M+H] 553.5; C 19H 11Br 2Cl 2F 3N 2+ H theoretical value 552.87.
Embodiment 314-(1-chlorodifluoramethyl-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Except heating 4 hours, use hexane: ether (8: 1) is made the isolating eluent of chromatogram and is not had beyond subsequently the crystallisation step, according to embodiment 27 described similarity methods, obtain a white solid, m.p.124-125 ℃ by preparation example 44 described title compounds. δ (CDCl 3): 1.24 (m, 2H), 1.58 (m, 2H), 7.74 (s, 1H), 7.74 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 446.9; C 15H 7Cl 3F 5N 3+ NH 4Theoretical value 447.0.
Embodiment 323-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-ethyl cyclopropyl) pyrazoles
In 2 minutes, the diethyl ether solution (30ml) of 0.467 M diazomethane joined in preparation example 47 described title compounds (3g) under stirring and acid chloride (II) ether (5ml) solution (0.025g) and and under room temperature, stirred 18 hours the gained mixture.Reaction mixture is filtered, use the diethyl ether solution (30ml) and the acid chloride (II) of diazomethane (0.025g) to handle again, restir 4 hours, filter, use the diethyl ether solution (30ml) and the acid chloride (II) of diazomethane (0.025g) to handle again, restir 40 hours, filter, further use the diethyl ether solution (30ml) and the acid chloride (II) of diazomethane (0.025g) to handle, stirred 88 hours, filter, further use the diethyl ether solution (30ml) of diazomethane and acid chloride (II) (0.025g) to handle restir 2 hours then again, filter, use the diethyl ether solution (30ml) and the acid chloride (II) of diazomethane (0.025g) to handle again,, stirred 18 hours and reduction vaporization.Resistates through the reversed-phase HPLC purifying, is used acetonitrile on C18 silica gel: water (60: 40) is made eluent, obtains the described title compound of white solid, m.p.118-119 ℃. δ (CDCl 3): 0.80 (m, 2H), 0.90 (m, 5H), 1.63 (m, 2H), 7.44 (s, 1H), 7.77 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 390.8; C 16H 12Cl 2F 3N 3+ NH 4Theoretical value 391.1.
Embodiment 333-cyano group-4-(2,2-two bromo-1-ethyl cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Toluene (4ml) solution of preparation example 47 described title compounds (105mg) and phenyl trisbromomethyl mercury (160mg) was heated 2 hours down in 70 ℃, add toluene (2ml) solution of phenyl trisbromomethyl mercury (180mg) then and mixture is descended heating 16 hours in 70 ℃, add phenyl trisbromomethyl mercury (230mg) again and mixture is descended heating 4 hours in 70 ℃, continuation is heated phenyl trisbromomethyl mercury (310mg) and mixture was heated 2 hours down in 70 ℃, add phenyl trisbromomethyl mercury (310mg) again and with mixture in 70 ℃ of down heating 16 hours, make its cooling then.The gained mixture filters through silica gel (10g), uses hexane, makes eluent with methylene dichloride then, with required wash-out stream part reduction vaporization.Resistates in silica gel (10g) through the column chromatography purifying, use methylene dichloride: hexane (1: 4) is made eluent, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (60: 30: 10) is made eluent, obtain the described title compound of white solid, m.p.107-108 ℃. δ (CDCl 3): 1.04 (t, 3H), 1.90 (m, 2H), 2.19 (m, 2H), 7.62 (s, 2H), 7.79 (s, 2H) .MS (thermospray): M/Z[M+H] 530.0; C 16H 10Br 2Cl 2F 3N 3+ H requires 529.9.
Embodiment 343-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-pentafluoroethyl group cyclopropyl) pyrazoles
Except on C18 silica gel through reversed-phase HPLC, use acetonitrile: water: methyl alcohol (60: 30: 10) is done beyond the eluent, according to embodiment 31 described similarity methods, obtains a white solid, m.p.105-106 ℃ by preparation example 50 described title compounds. δ (CDCl 3): 1.24 (m, 2H), 1.55 (m, 2H), 7.67 (s, 1H), 7.77 (s, 2H) .MS (electron spray(ES)): M/Z[M+H] 464.0; C 16H 7Cl 2F 8N 3+ H theoretical value 464.0.
Embodiment 353-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-seven fluoropropyl cyclopropyl) pyrazoles
Except heated 3 hours and in chromatographic separation after the hexanaphthene crystallization,, obtain a white solid, m.p.95-96 ℃ by preparation example 53 described title compounds according to embodiment 31 described similarity methods. δ (CDCl 3): 1.23 (m, 2H), 1.54 (m, 2H), 7.65 (s, 1H), 7.74 (s, 2H) .MS (thermal spray): M/Z[M+H] 514.2; C 17H 7Cl 2F 10N 3+ H theoretical value 514.0.
Embodiment 365-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles
The dimethylbenzene (8ml) and toluene (1ml) mixture solution of preparation example 55 described title compounds (130mg) were heated 7 hours under the gentle reflux condition, make it under room temperature, leave standstill then 16 hours.Remove solvent under reduced pressure, the gained resistates through the reversed-phase HPLC purifying, is used acetonitrile on C18 silica gel: water: methyl alcohol (45: 45: 10) is made eluent, obtains the described title compound of white solid, m.p.178-179 ℃. δ (CDCl 3): 1.13 (m, 2H), 1.48 (m, 2H), 3.91 (br.s, 2H), 7.80 (s, 2H) .MS (thermospray): M/Z [M+H] 429.1; C 15H 8Cl 2F 6N 4+ H requires 429.0.
Embodiment 371-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-(2,2-dibromo cyclopropyl) pyrazoles
Toluene (5ml) solution of preparation example 58 described title compounds (0.50g) and phenyl trisbromomethyl mercury (1.0g) was heated 1.5 hours down for 70 ℃ in nitrogen atmosphere, add phenyl trisbromomethyl mercury (0.50g) again and continue heating 72 hours.Make the cooling of gained mixture, partition between ether and water, water phase separated is also used ether (x2) extraction.With extraction liquid water and the saturated brine washing successively that merges, dry (MgSO 4) and reduction vaporization.With brown oily crude product (0.50g) on silica gel through the column chromatography purifying, use hexane: ethyl acetate (9: 1) is made eluent, obtains the described title compound of yellow solid shape, m.p.81-83C. δ (CDCl 3): 2.05 (t, 1H), 2.33 (dd, 1H), 2.85 (dd, 1H), 8.20 (s, 1H), 8.23 (s, 1H), 8.70 (s, 1H) .MS (thermal spray): M/Z[M+H] 467.9; C 13H 6Br 2ClF 3N 4+ H theoretical value 467.9.
Embodiment 383-ethanoyl-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Under nitrogen atmosphere, ether (25ml) solution of embodiment 2 described title compounds (3.42g) is joined in the diethyl ether solution (2.26ml) and anhydrous diethyl ether (25ml) mixture that stirs 3.0 ice-cooled down M methyl magnesium iodides, keep temperature of reaction to be lower than 2 ℃ simultaneously.Reaction mixture is warmed to room temperature, and heating is 2 hours under refluxing, and with using 3M methyl magnesium iodide diethyl ether solution (0.5ml) to handle again, this mixture is refluxed heated 1 hour down then, stirs 18 hours under room temperature then.Add the methyl magnesium iodide diethyl ether solution (1ml) of volume more and the heating down 3 hours that will the gained mixture refluxes, be poured into then and stir concentrated hydrochloric acid (2ml) down and ice in (10g) mixture.With ether (x3) extraction, subsequently with the extraction liquid of salt water washing merging, dry (MgSO 4) and reduction vaporization, obtain crude product, with its on silica gel through the column chromatography purifying, use hexane: methylene dichloride (1: 1) is made eluent, crystallization in hexane subsequently obtains the described title compound of faint yellow solid shape, m.p.149.5-150.3 ℃. δ (CDCl 3): 1.78 (dd, 1H), 2.24 (dd, 1H), 2.69 (s, 3H), 3.37 (dd, 1H), 7.34 (s, 1H), 7.78 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 536.3; C 15H 9Br 2Cl 2F 3N 2O+NH 4Theoretical value 535.88.
Embodiment 394-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-(1-hydroxyethyl) pyrazoles
Under about-50 ℃ of nitrogen atmosphere, with 1 M borine: the tetrahydrofuran solution of tetrahydrofuran (THF) mixture (4.61ml) joins in anhydrous tetrahydro furan (5ml) solution of the embodiment 38 described title compounds (0.40g) under stirring, reaction mixture is warmed to room temperature, further stirred 4 hours.Reduction vaporization then.Resistates through the column chromatography purifying, is used hexane on silica gel: ether (3: 1) is made eluent, obtains the described title compound of oil-containing white solid.δ (CDCl 3): 1.55 (s, 1H), 1.75 (d, 3H), 1.80 (t, 1H), 2.20 (dd, 1H), 2.95 (dd, 1H), 5.20 (m, 1H), 7.25 (s, 1H), 7.70 (s, 2H) .MS (thermal spray): M/Z[M+H] 521.0; C 15H 11Br 2Cl 2F 3N 2O+H theoretical value 520.86.
Embodiment 404-(2,2-dibromo cyclopropyl)-1-(2.6-dichlor-4-trifluoromethyl phenyl)-3-ethyl pyrazoles
Under about-75 ℃, triethyl silicane (0.22ml) is joined in methylene dichloride (5ml) solution of the embodiment 39 described title compounds (0.18g) under stirring, keep temperature of reaction to be lower than-70 ℃ simultaneously.Add boron-trifluoride etherate (0.17ml) and reaction mixture is warmed to room temperature, further stirred then 24 hours.Subsequently, mixture is cooled to-70 ℃, adds triethyl silicane (0.22ml) and boron-trifluoride etherate (0.17ml) again, remove cooling bath and at room temperature continue and stirred 4 days.The gained mixture washs with dilute hydrochloric acid, and water extracts with methylene dichloride (x2).The organic solution salt water washing that merges, dry (Na 2SO 4) and reduction vaporization, then with resistates on silica gel through the column chromatography purifying, use hexane: ether (2: 1) is made eluent, obtains the described title compound of colorless oil.δ (CDCl 3): 1.45 (t, 3H), 1.80 (t, 1H), 2.20 (dd, 1H), 2.65 (dd, 1H), 2.85 (q, 2H), 7.20 (s, 1H), 7.70 (s, 2H) .MS (thermal spray): M/Z[M+H] 504.9; C 15H 11Br 2Cl 2F 3N 2+ H theoretical value 504.87.
Embodiment 414-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-(2-hydroxyl third-2-yl) pyrazoles
Under nitrogen atmosphere, ether (5ml) solution of embodiment 38 described title compounds (0.30g) joined stir in the ice-cooled down 3.0 M methyl iodate magnesium solutions (0.21ml) and anhydrous diethyl ether (5ml) mixture, keep temperature of reaction to be lower than 2 ℃ simultaneously.Reaction mixture is warmed to room temperature, and the heating down 1 hour that refluxes makes its cooling, is poured into then in the concentrated hydrochloric acid (2ml) and ice (10g) mixture under stirring.With ether (x3) extraction, subsequently with the extraction liquid of salt water washing merging, dry (MgSO 4) and reduction vaporization, obtain crude product, with its crystallization in toluene, obtain the described title compound of white solid, m.p.132.1-132.7 ℃. δ (CDCl 3): 1.80 (s, 6H), 1.82 (t, 1H), 2.20 (dd, 1H), 2.55 (s, 1H), 3.05 (dd, 1H), 7.20 (s, 1H), 7.70 (s, 2H) .MS (thermal spray): M/Z[M+H] 534.4; C 16H 13Br 2Cl 2F 3N 2O+H theoretical value 534.88.
Embodiment 424-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-(third-2-yl) pyrazoles
Under about-75 ℃, triethyl silicane (0.14ml) is joined in methylene dichloride (5ml) solution of the embodiment 41 described title compounds (0.115g) under stirring, keep temperature of reaction to be lower than-70 ℃ simultaneously.Add boron-trifluoride etherate (0.11ml) and with reaction mixture in approximately-70 ℃ kept 2.5 hours down, make it be warmed to room temperature afterwards.After 24 hours, mixture washs with dilute hydrochloric acid, and water extracts with methylene dichloride (x2).The organic solution salt water washing that merges, dry (Na 2SO 4) and reduction vaporization, obtain crude product, with its on silica gel through the column chromatography purifying, use hexane: ether (4: 1) is made eluent, obtains the described title compound of colorless oil.δ (CDCl 3): 1.40 (d, 6H), 1.80 (t, 1H), 2.20 (dd, 1H), 2.70 (dd, 1H), 3.20 (sept., 1H), 7.15 (s, 1H), 7.70 (s, 2H) .MS (thermal spray): M/Z[M+H] 518.4; C 16H 13Br 2Cl 2F 3N 2+ H theoretical value 518.89.
Embodiment 434-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-formyl radical pyrazoles
Hexane solution (1.5ml) with 1 M diisobutyl aluminium hydride in 5 minutes is added drop-wise in anhydrous tetrahydro furan (15ml) solution of refrigerative embodiment 2 described title compounds (0.50g) under the stirring.After 1 hour, reaction mixture further uses hydride solution (2.25ml) to handle, and stirs 18 hours, then in the impouring acidifying methanol aqueous solution.Mixture extracts with ether (x2), and the extraction liquid of merging is water and salt water washing successively, dry (MgSO 4) and reduction vaporization.The gained resistates through the column chromatography purifying, is used hexane on silica gel; Ethyl acetate (9: 1) is made eluent, obtains the described title compound of oily.δ (CDCl 3): 1.80 (dd, 1H), 2.28 (dd, 1H), 3.32 (dd, 1H), 7.39 (s, 1H), 7.78 (s, 2H), 10.19 (s, 1H) .MS (thermal spray): M/Z[M+H] 504.7; C 14H 7Br 2Cl 2F 3N 2O+H theoretical value 504.83.
Embodiment 444-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-difluoromethyl pyrazole
Diethylaminosulfurtrifluoride (0.13g) is joined in methylene dichloride (5ml) solution of the embodiment 43 described title compounds (0.20g) under stirring, under the room temperature again through after 3 hours, reaction mixture dilutes with methylene dichloride, water (x2) washing, dry (MgSO 4) and reduction vaporization.Resistates through the column chromatography purifying, is used hexane on silica gel: ethyl acetate (19: 1) is made eluent, obtains the described title compound of white solid, m.p.99-101 ℃. δ (CDCl 3): 1.85 (t, 1H), 2.25 (dd, 1H), 2.95 (dd, 1H), 6.87 (t, 1H), 7.38 (s, 1H), 7.74 (s, 2H) .MS (thermal spray): M/Z[M+H] 526.5; C 14H 7Br 2Cl 2F 5N 2+ H theoretical value 526.84.
Embodiment 454-(2,2-dibromo cyclopropyl)-3-dichloromethyl-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Phosphorus pentachloride (0.17g) is joined in ether (10ml) solution of the embodiment 43 described title compounds (0.20g) under stirring, after 24 hours, add phosphorus pentachloride (0.17g) again, reaction mixture further stirred 24 hours, afterwards reduction vaporization.Resistates through the column chromatography purifying, is used hexane on silica gel: ethyl acetate (19: 1) is made eluent, obtains the described title compound of white solid, m.p.87-89 ℃. δ (CDCl 3): 1.90 (t, 1H), 2.29 (dd, 1H), 3.12 (dd, 1H), 6.96 (s, 1H), 7.30 (s, 1H), 7.72 (s, 2H) MS (APCl): M/Z[M+H] 559.2; C 14H 7Br 2Cl 4F 3N 2+ H theoretical value 558.78.
Embodiment 463-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,4, the 6-trichlorophenyl) pyrazoles
With preparation example 61 described title compounds (2.0g), with the stirring 6 hours rapidly under about 40 ℃ of gentle reflux conditions of the mixture of 1-3% ethanol stable 96% bromofom (6.5ml), sodium hydroxide (1.0g), water (1.0ml), ethanol (0.14ml), methylene dichloride (6.5ml) and benzyltriethylammoinium chloride (80mg), under room temperature, stirred 18 hours then, stirred 6 hours down in about 40 ℃ again.Add sodium hydroxide (0.3g), water (0.6ml) and quaternary ammonium salt catalyst (130mg) again, reaction mixture stirred 18 hours under room temperature then in about 40 ℃ of following vigorous stirring 6 hours.Add catalyzer (100mg) again, reaction mixture stirred 6 hours under about 40 ℃, stirred 66 hours under room temperature then.Continue to add catalyzer (100mg) and methylene dichloride (2.0ml), reaction mixture stirred 6 hours under about 40 ℃, stirred 18 hours under the room temperature, and about 40 ℃ were stirred 7 hours down, stirred under the room temperature 18 hours, about 40 ℃ stirred 7 hours down and room temperature under stirred 18 hours.At last, add 96% bromofom (3.0ml), 50% aqueous sodium hydroxide solution (0.5ml), methylene dichloride (3.0ml) and catalyzer (150mg) again and the gained mixture was stirred for 1 week under room temperature, then partition between methylene dichloride (100ml) and water (50ml).Isolating organic phase water (50ml) washing, dry (Na 2SO 4) and reduction vaporization, obtain a black jelly, it is gone up through the column chromatography purifying in silica gel (100g), use hexane, use hexane then: ether: methylene dichloride (8: 1: 1) is made eluent, obtains the very light described title compound of yellow solid shape, m.p.164 ℃. δ (CDCl 3): 2.02 (t, 1H), 2.34 (dd, 1H), 2.87 (dd, 1H), 7.48 (s, 1H), 7.51 (s, 2H) .MS (thermal spray): M/Z[M+NH 4] 484.6; C 13H 6Br 2Cl 3N 3+ NH 4Theoretical value 484.8.
Embodiment 473-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,4, the 6-trichlorophenyl) pyrazoles
The mixture of preparation example 61 described title compounds (2.0g), chloroform (6.0ml), sodium hydroxide (1.0g), water (1.0ml), ethanol (0.2ml), methylene dichloride (6.5ml) and benzyltriethylammoinium chloride (150mg) was stirred 66 hours rapidly down in about 40 ℃.Add sodium hydroxide (0.5g), water (1.0ml), methylene dichloride (4ml) and quaternary ammonium salt catalyst (180mg) again, reaction mixture stirred 90 hours down in about 40 ℃.Add catalyzer (150mg), methylene dichloride (5.0ml), 50% aqueous sodium hydroxide solution (0.5ml) and chloroform (3.0ml) again, the gained mixture was stirred 10 days under about 36 ℃, then partition between methylene dichloride (100ml) and water (50ml).Isolating organic phase water (50ml) washing, dry (Na 2SO 4) and reduction vaporization, obtain a black jelly, it is gone up through the column chromatography purifying in silica gel (80g), use hexane: ether: methylene dichloride (8: 1: 1) is made eluent, obtains the described title compound of faint yellow solid shape, m.p.157.8 ℃. δ (CDCl 3): 1.85 (t, 1H), 2.19 (dd, 1H), 2.85 (dd, 1H), 7.49 (s, 1H), 7.52 (s, 2H) .MS (thermal spray): [M/Z+NH 4] 396.8; C 13H 6Cl 5N 3+ NH 4Theoretical value 396.9.
Embodiment 485-amino-3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles
(2,6-two chloro-4-five fluorine sulfenyl phenyl)-(WO-A-97/07 102 for 4-vinyl pyrazoles with the amino of the 5-under the vigorous stirring-3-cyano group-1-; 0.50g), the heating down 18 hours that refluxes of the mixture of chloroform (3.0ml), sodium hydroxide (0.25ml) water (0.25ml) solution, ethanol (2), methylene dichloride (2.0ml) and benzyltriethylammoinium chloride (25mg), and then add chloroform (3.0ml) and quaternary ammonium salt catalyst (25mg) and continue stirring 78 hours down in refluxing.Add chloroform (3.0ml) and catalyzer (25mg) again, the gained mixture stirred 4 days down in refluxing, then partition between methylene dichloride (30ml) and water (30ml).Isolating organic phase water (2 * 20ml) and saturated brine (20ml) washing, dry (Na 2SO 4) and reduction vaporization, obtain a chocolate oily matter.With this crude product purifying as described below: (i) make the solvent preadsorption to silica gel (1.5g) with methylene dichloride, carry out column chromatography subsequently and separate on silica gel (20g), use hexane: ethyl acetate (7: 3) is made eluent; (ii) carry out reversed-phase HPLC on C18 silica gel, use acetonitrile: water (70: 30) is made eluent; (iii) carry out reversed-phase HPLC on C18 silica gel again, use acetonitrile: methyl alcohol: water (50: 10: 40) is made eluent; Obtain the described title compound of pale solid shape, m.p.90-95 ℃. δ (CDCl 3): 2.23 (m, 2H), 2.56 (t, 1H), 3.84 (br.s, 2H), 7.83 (s, 2H) .MS (thermal spray): M/Z[M+H] 487.3; C 13H 7Cl 4F 5N 4S+H theoretical value 486.9.
Embodiment 493-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles
Described reaction is made raw material with 3-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-vinyl pyrazoles (WO-A-97/07 102) and is carried out with embodiment 48 described methods.Thick chocolate oily matter is purifying as described below: (i) make the solvent preadsorption to silica gel (1.5g) with methylene dichloride, carry out column chromatography subsequently and separate on silica gel (15g), use hexane: ether: methylene dichloride (8: 1: 1) is made eluent; (ii) the faint yellow oily thing of gained is developed with isopropyl ether, and subsequent filtration and with filtrate evaporated under reduced pressure obtains a yellow oil, makes it leave standstill curing; (iii) carry out reversed-phase HPLC on C18 silica gel, use acetonitrile: water (70: 30) is made eluent; (iv), use hexane, make eluent with methylene dichloride then in carrying out reversed-phase HPLC on the C18 silica gel with hexane wash in advance; (v) gained oily matter is dissolved in the methyl alcohol, in described solution, adds entry then until becoming muddy, with postcooling; Obtain the described title compound of white solid, m.p.78-80 ℃, δ (CDCl 3): 1.87 (t, 1H), 2.20 (m, 1H), 2.85 (m, 1H), 7.53 (s, 1H), 7.93 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 489.1; C 13H 6Cl 4F 5N 3S+NH 4Theoretical value 488.9.
Preparation example 15-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodine pyrazoles
In 5 minutes under the room temperature, N-iodosuccinimide (3.52g) is joined 5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles (EP-A-0295117 under stirring in batches; 5.0g) acetonitrile (60ml) solution in, stir after 1 hour, with the reaction mixture reduction vaporization, obtain required crude product (8.2g), although it still contains succinimide, can need not to be further purified use.
If desired, can between methylene dichloride and water, partition carry out purifying, separate and dry (MgSO described crude product 4) organic phase, with its reduction vaporization, then the gained yellow solid is developed with hexane, obtain the described title compound of white solid, m.p.213 ℃ (decomposition).
Preparation example 25-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl pyrazoles
Under the room temperature, three-normal-butyl (vinyl) tin (4.25g) and four (triphenyl phosphine) palladium (0) (0.3g) are joined in dimethyl formamide (10ml) solution that stirs preparation example 1 described title compound (2.0g) down and with the gained mixture and heated 1 hour down in 75 ℃, restir 60 hours under room temperature, dilute with water afterwards then.The mixture extracted with diethyl ether, the salt water washing of the extraction liquid of merging, dry (MgSO 4) and reduction vaporization, obtain a dark oil crude product (6.0g), it is gone up through the column chromatography purifying in silica gel (200g), use hexane: methylene dichloride (1: 1) is made eluent, obtains the described title compound of beige solid shape, and m.p.186-187 ℃, δ (CDCl 3): 3.85 (s, 2H), 5.41 (d, 1H), 5.70 (d, 1H), 6.52 (dd, 1H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+H] 347.0; C 13H 7Cl 2F 3N 4+ H theoretical value 347.0.
Preparation example 33-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodine pyrazoles
In 65 ℃ in 30 minutes, nitrous acid tertiary butyl ester (144ml) is joined in tetrahydrofuran (THF) (720ml) solution of the preparation example 1 described title compound (90g) under stirring.In 65 ℃ after 3 hours, make reaction mixture cooling and reduction vaporization, then with resistates crystallization in propyl alcohol, obtain the described title compound of white solid, m.p.83-84 ℃, δ (CDCl 3): 7.70 (s, 1H), 7.79 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 448.8; C 11H 3Cl 2F 3IN 3+ NH 4Theoretical value 448.9.
Preparation example 43-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl pyrazoles
Dimethyl formamide (350ml) solution of preparation example 3 described title compounds (58g), three-normal-butyl (vinyl) tin (116mg) and four (triphenyl phosphine) palladium (3.5g) was stirred 3 hours down in 75 ℃, make its cooling then.With reaction mixture partition between ether (600ml) and water (600ml), organic phase is water (x5) and salt water washing successively, dry (Na 2SO 4) and reduction vaporization.Resistates is crystallization in propan-2-ol, obtains the described title compound of filbert solid state, and m.p.75-76 ℃, δ (CDCl 3): 5.50 (d, 1H), 5.94 (d, 1H), 6.64 (dd, 1H), 7.64 (s, 1H), 7.77 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 349.5; C 13H 6Cl 2F 3N 3+ NH 4Theoretical value 349.02.
Preparation example 55-amino-3-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-iodine pyrazoles
In following 5 minutes of room temperature, N-iodosuccinimide (11.5g) is joined 5-amino-3-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles (WO-A-93/06089 under stirring in batches; 18.95g) acetonitrile (100ml) solution in, after 15 minutes, with the reaction mixture reduction vaporization, remaining solid is with the mixture process of methylene dichloride and water.Filter and collect insolubles and be dissolved in ethyl acetate, then with this solution drying (Na 2SO 4) and reduction vaporization, obtain the described title compound of beige solid shape, m.p.253 ℃, δ (CDCl 3): 3.94 (br.s, 2H), 7.92 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 521.9; C 10H 4Cl 2F 5IN 4S+NH 4Theoretical value 521.88.
Preparation example 65-amino-3-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-vinyl pyrazoles
Under the room temperature, three-normal-butyl (vinyl) tin (4.5ml) joined stir down, heated 30 minutes down in 70 ℃ in the preparation example 5 described title compounds (5.05g) of the degassing and four (triphenyl phosphine) palladium (O) dimethyl formamide (32ml) solution (0.175g) and with the gained mixture.In 70 ℃ after following 1 hour, add three-normal-butyl (vinyl) tin (4.5ml) and four (triphenyl phosphine) palladium (O) and (0.175g) and with reaction mixture heated 1 hour down, then reduction vaporizations in 70 ℃.Resistates is partition between ether and water, and the ether extraction liquid of isolating organic phase and water merges, and uses the salt water washing, dry (MgSO 4) and reduction vaporization, obtain a brown mashed prod, it is developed with hexane.The gained brown solid is handled with ethyl acetate, and mixture is filtered, and with filtrate evaporated under reduced pressure, resistates is crystallization in toluene, obtains the described title compound of beige solid shape, and m.p.227-228 ℃, δ (CDCl 3): 3.86 (s, 2H), 5.41 (d, 1H), 5.68 (d, 1H), 6.50 (dd, 1H), 7.92 (s, 2H).MS (thermal spray): M/Z[M+H] 405.1; C 12H 7Cl 2F 5N 4S+H theoretical value 404.98.
Preparation example 73-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-iodine pyrazoles
In 30 minutes, tetrahydrofuran (THF) (15ml) drips of solution of nitrous acid tertiary butyl ester (3.1g) is added in tetrahydrofuran (THF) (35ml) solution of preparation example 5 described title compounds (2.5g), then with the reaction mixture reduction vaporization.Resistates is crystallization in propan-2-ol, obtains the described title compound of pink solid shape, and m.p.179-180 ℃, δ (CDCl 3): 7.66 (s, 1H), 7.90 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 506.4; C 10H 3Cl 2F 5IN 3S+NH 4Theoretical value 506.87.
Preparation example 83-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-vinyl pyrazoles
Under the room temperature, three-normal-butyl (vinyl) tin (4.2ml) joined stir down, heated 1.5 hours down in 70 ℃ in the preparation example 7 described title compounds (1.23g) of the degassing and four (triphenyl phosphine) palladium (O) dimethyl formamide (32ml) solution (0.09g) and with the gained mixture, afterwards reduction vaporization.Resistates with hexane development and with the gained solid by being dissolved in methylene dichloride and going up through the column chromatography purifying at silica gel (60g), use hexane, use hexane then: methylene dichloride (80: 20) is made eluent, obtains the described title compound of white solid, m.p.156 ℃, δ (CDCl 3): 5.50 (d, 1H), 5.95 (d, 1H), 6.63 (dd, 1H), 7.77 (s, 1H), 7.92 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 406.8; C 12H 6Cl 2F 5N 3S+NH 4Theoretical value 406.99.
Preparation example 93-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-formyl radical pyrazoles
The t-butanol solution (50 μ l) of preparation example 4 described title compounds (0.1g), 2.5wt.% perosmic anhydride and 90% aqueous acetone solution of 4-methylmorpholine-N-oxide compound (0.005g) were stirred under room temperature 16 hours.Add sodium metaperiodate (0.005g) and with reaction mixture restir 16 hours, reduction vaporization then.Resistates is partition between ether and saturated sodium bicarbonate aqueous solution, and water phase separated is also used extracted with diethyl ether, with the ether extraction liquid drying (Na that merges 2SO 4) and reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (5g), makes eluent with methylene dichloride, obtains the described title compound of beige solid state, and m.p.167.5-168.5 ℃, δ (CDCl 3): 7.80 (s, 2H), 8.18 (s, 1H), 10.08 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 351.3; C 12H 4Cl 2F 3N 3O+NH 4Theoretical value 351.0.
Preparation example 103-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(2-methacrylic-1-yl) pyrazoles
Under the room temperature, the hexane solution (0.9ml) of 2.5 M n-Butyl Lithiums is joined in anhydrous diethyl ether (10ml) solution that stirs the basic triphenyl phosphonium iodide of third-2-down (0.97g), obtain a dark red solution.Add ether (20ml) solution of preparation example 9 described title compounds (0.6g) and reaction mixture was stirred 2 hours water (20ml) washing, dry (MgSO 4) and reduction vaporization.Resistates through the column chromatography purifying, is made eluent with methylene dichloride on silica gel, obtain the described title compound of filbert solid state, and m.p.72-74 ℃, δ (CDCl 3): 1.90 (s, 3H), 1.99 (s, 3H), 6.17 (s, 1H), 7.60 (s, 1H), 7.77 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 360.2; C 15H 10Cl 2F 3N 3+ NH 4Theoretical value 360.03.
Preparation example 115-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-trimethyl silyl vinyl pyrazoles
Under the room temperature trimethyl silyl acetylene (3ml), cuprous iodide (150mg) and two (triphenyl phosphine) palladium (II) (300mg) are joined in the triethylamine (30ml) that stirs preparation example 1 described title compound (6.96g) down and dimethyl formamide (6ml) mixture solution and with the gained mixture to descend to heat 1 hour in 50-60 ℃.Add trimethyl silyl acetylene (0.3ml) again, then reaction mixture was stirred 30 minutes down in 50-60 ℃, make its cooling and water (250ml) dilution.This mixture helps to be separated with salt solution with ether (250ml) extraction, water phase separated, and extract with ether (250ml).With the ether extraction liquid drying (MgSO that merges 4) and reduction vaporization, obtain a jelly, with its on silica gel through the column chromatography purifying, use hexane: methylene dichloride (1: 1) is made eluent, and products therefrom crystallization in hexane-ether subsequently so obtains the described title compound of white solid, m.p.181-182 ℃, δ (CDCl 3): 0.20 (s, 9H), 4.10 (br.s, 2H), 7.70 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 434.2; C 16H 13Cl 2F 3N 4Si+NH 4Theoretical value 434.0.
Preparation example 125-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl pyrazoles
Salt of wormwood (1.0g) is joined in methyl alcohol (30ml) solution of the preparation example 11 described title compounds (2.0g) under stirring.After following 10 minutes,, separate organic phase then in room temperature with reaction mixture partition between ether (100ml) and water (100ml), with salt solution (100ml) washing, dry (MgSO 4) and reduction vaporization.Resistates through the column chromatography purifying, is made eluent with methylene dichloride on silica gel, crystallization in ether subsequently obtains the described title compound of white solid, and m.p.215-216 ℃, δ (CDCl 3): 3.49 (s, 1H), 4.20 (br.s, 2H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 362.4; C 13H 5Cl 2F 3N 4+ NH 4Theoretical value 362.0.
Preparation example 134-ethanoyl-5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Tosic acid (0.5g) is joined in acetonitrile (5ml) solution of the preparation example 12 described title compounds (0.345g) under stirring.After following 2 hours of the room temperature,, separate organic phase, use the saturated bicarbonate aqueous solution and salt water washing successively, dry (Na reaction mixture partition between ether (100ml) and water (100ml) 2SO 4) and reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (40g), and use hexane: methylene dichloride (1: 10) is made eluent, obtains the described title compound of white crystalline solid shape, and m.p.200-201 ℃, δ (CDCl 3): 2.65 (s, 3H), 5.83 (br.s, 2H), 7.82 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 380.4; C 13H 7Cl 2F 3N 4O+NH 4Theoretical value 380.03.
Preparation example 144-ethanoyl-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Nitrous acid tertiary butyl ester (0.0262ml) is added drop-wise in tetrahydrofuran (THF) (2ml) solution of the preparation example 13 described title compounds (0.4g) under stirring.With heating under the reaction mixture refluxed 30 minutes, be added to then on silica gel (1.0g) post, use the tetrahydrofuran (THF) wash-out, obtain the described title compound of white solid, m.p.166-168 ℃, δ (CDCl 3): 2.67 (s, 3H), 7.80 (s, 2H), 8.12 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 365.0; C 13H 6Cl 2F 3N 3O+NH 4Theoretical value 365.02.
Preparation example 153-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-methyl ethylene) pyrazoles
The tetrahydrofuran solution (0.64ml) of 2.5 M n-Butyl Lithiums is joined in anhydrous diethyl ether (10ml) suspension of the Jia base triphenyl phosphonium bromide (0.565g) under stirring, obtain a yellow solution, to anhydrous tetrahydro furan (10ml) solution that wherein adds preparation example 14 described title compounds (0.5g).Reaction mixture heated 4 hours down in 30 ℃, made its cooling and partition between ether (100ml) and saturated sodium bicarbonate aqueous solution (100ml).Separate organic phase, dry and reduction vaporization, resistates through the column chromatography purifying, is used hexane on silica gel: methylene dichloride (1: 9) is made eluent, obtains the described title compound of white solid, and m.p.129-130 ℃, δ (CDCl 3): 2.16 (s, 3H), 5.29 (s, 1H), 5.80 (s, 1H), 7.59 (s, 1H), 7.88 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 362.9; C 14H 8Cl 2F 3N 3+ NH 4Theoretical value 363.04.
Preparation example 163-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-(2-iodo-1-methoxy ethyl) pyrazoles
Red precipitate (0.325g) and iodine (0.381g) are joined in methyl alcohol (10ml) solution of the preparation example 8 described title compounds (0.5g) under stirring, and the heating down 3 hours that then the gained mixture refluxed makes its cooling and reduction vaporization.Resistates through the column chromatography purifying, is made eluent with methylene dichloride on silica gel, obtain the described title compound of yellow solid shape, and m.p.92-94 ℃, δ (CDCl 3): 3.46 (s, 3H), 3.54 (m, 2H), 4.49 (t, 1H), 7.70 (s, 1H), 7.78 (s, 2H).
Preparation example 173-cyano group-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl)-4-(1-methoxy-ethylene base) pyrazoles
With 1,8-diazabicylo [5.4.0] 11 carbon-7-alkene (0.064g) joins in toluene (10ml) solution of the preparation example 16 described title compounds (0.2g) under stirring.After following 18 hours of the room temperature, with the reaction mixture reduction vaporization, resistates through the column chromatography purifying, is used hexane on silica gel: methylene dichloride (1: 5) is made eluent, obtains the described title compound of white solid, and m.p.116-118 ℃, δ (CDCl 3): 3.75 (s, 3H), 4.45 (d, 1H), 4.98 (d, 1H), 7.78 (s, 2H+1H).MS (thermal spray): M/Z[M+H] 362.1; C 14H 8Cl 2F 3N 3O+H theoretical value 362.01.
Preparation example 18N-[3-cyano group-1-(2; 6-dichlor-4-trifluoromethyl phenyl) pyrazol-4-ylmethylene]-N '-(4-aminomethyl phenyl alkylsulfonyl) hydrazine; lithium salts stirred the tetrahydrofuran solution of preparation example 9 described title compounds (0.333g) and p-toluenesulfonyl hydrazine (0.186g) 10 minutes under room temperature; add 3A molecular sieve (2, about 0.011g) then.Under the nitrogen atmosphere mixture is cooled to-78 ℃ and in 3 minutes, add the hexane solution (0.4ml) of 2.5 M n-Butyl Lithiums, makes reaction mixture be warmed to room temperature,, filter and filtrate is handled with hexane (40ml).Filter and collect gained precipitation and dry, obtain the described title compound of white solid.δ(DMSOd 6)：2.28(s，3H)，7.10(d，2H)，7.45(s，1H)，7.68(d，2H)，8.23(s，1H)，8.28(s，2H)。MS (thermal spray): M/Z[M+H] 507.8; C 19H 11Cl 2F 3N 5O 2SLi+H theoretical value 508.02.
Preparation example 195-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-methylpyrazole
3-aminobutene nitrile (5.0g) is joined 2 under the stirring, and in ethanol (100ml) solution of 6-dichlor-4-trifluoromethyl phenyl hydrazine (15.0g), gained solution is handled with the vitriol oil (1.0ml) then, obtains the white solid precipitation.With the mixture heating down 6 hours that refluxes, make its cooling and restir 18 hours under room temperature; Repeat this circulation, add the vitriol oil (4ml) again.Reaction mixture was heated 8 hours down in 60 ℃, make its cooling, under room temperature, stirred 18 hours and reduction vaporization.With gained orange partition between methylene dichloride (100ml) and water (100ml), then with the organic phase drying, make it under room temperature, leave standstill 18 hours, remove by filter some white solids.With filtrate evaporated under reduced pressure, obtain an orange, it is developed with hot hexane.Cooling, deposition one yellow oil makes its slow crystallization in the hexane solution, obtains the described title compound of white solid, m.p.80-83 ℃.Found：C，42.73；H，2.62；N，13.58。C 11H 8Cl 2F 3N 3Theoretical value C, 42.61; H, 2.60; N, 13.55%.δ(CDCl 3)：2.25(s，3H)，3.48(br.s，2H)，5.52(s，1H)，7.70(s，2H)。MS (thermal spray): M/Z[M] 310.0; C 11H 8Cl 2F 3N 3Theoretical value 310.12.
Preparation example 205-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-methylpyrazole
Under the room temperature, N-iodosuccinimide (5.5g) is joined in acetonitrile (200ml) solution of the preparation example 19 described title compounds (9.0g) under stirring.With heating under the reaction mixture refluxed 1 hour, left standstill under the room temperature 18 hours, then reduction vaporization.The hot hexane extraction of resistates reclaims the precipitation and the drying that generate in the cold hexane solution, obtains the described title compound of pale solid shape, and m.p.116-118 ℃, δ (CDCl 3): 2.24 (s, 3H), 3.68 (br.s, 2H), 7.74 (s, 2H).MS (thermal spray): M/Z[M+H] 435.8; C 11H 7Cl 2F 3IN 3+ H theoretical value 435.91.
Preparation example 211-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-methylpyrazole
Under 0 ℃, nitrous acid tertiary butyl ester (2.33ml) is added drop-wise in tetrahydrofuran (THF) (35ml) solution of preparation example 20 described title compounds (2.85g).Make reaction mixture be warmed to room temperature, heating down 1.5 hours, reduction vaporization then reflux.Resistates on silica gel through the column chromatography purifying, use hexane: methylene dichloride (1: 1) is made eluent, obtain a yellow oil, it is further purified with similarity method, use hexane: methylene dichloride (2: 1) is made eluent, so obtain the described title compound of white solid, m.p.118.5-119.4 ℃, δ (CDCl 3): 2.18 (s, 3H), 7.54 (s, 1H), 7.70 (s, 2H).MS (thermal spray): M/Z[M+H] 420.5; C 11H 6Cl 2F 3IN 2+ H theoretical value 420.90.
Preparation example 221-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl-3-methylpyrazole
With four (triphenyl phosphine) palladium (O) (0.1g) and three-normal-butyl (vinyl) tin (2ml) join in dimethyl formamide (25ml) solution that stirs preparation example 21 described title compounds (2.06g) down and and heated 2 hours down, reduction vaporizations then in 70 ℃ with reaction mixture.Resistates is partition between ether and water, and water phase separated is also used ether (x2) extraction, the salt water washing of the organic solution of merging, dry (Na 2SO 4) and reduction vaporization.Resistates through the column chromatography purifying, is used hexane on silica gel: ether (9: 1) is made eluent, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: water: methyl alcohol (40: 50: 10) is made eluent, obtain the described title compound of white solid, m.p.68.1-68.7 ℃, δ (CDCl 3): 2.44 (s, 3H), 5.24 (d, 1H), 5.50 (d, 1H), 6.62 (dd, 1H), 7.57 (s, 1H), 7.74 (s, 2H).MS (thermal spray): M/Z[M+H] 321.1; C 13H 9Cl 2F 3N 2+ H theoretical value 321.02.
Preparation example 231-(2,6-dichlor-4-trifluoromethyl phenyl)-3
Under the room temperature, with penta-2,2 under 4-diketone (0.100g) joins and stirs in ethanol (4.5ml) solution of 6-dichlor-4-trifluoromethyl phenyl hydrazine (0.245g), adds Glacial acetic acid (0.5ml) subsequently.With heating under the reaction mixture refluxed 1 hour, reduction vaporization then.Resistates through the column chromatography purifying, is made eluent with methylene dichloride on silica gel, obtain a colorless oil at first, with its crystallization, after vacuum is removed excessive solvent, obtains m.p.87-89 ℃ of described title compound (0.265g), δ (CDCl 3): 2.10 (s, 3H), 2.32 (s, 3H), 6.07 (s, 1H), 7.72 (s, 2H).MS (thermal spray): M/Z[M] 309.0; C 12H 9Cl 2F 3N 2Theoretical value 309.12.
Preparation example 241-(2,6-dichlor-4-trifluoromethyl phenyl)-3,5-dimethyl-4-iodine pyrazoles
Under the room temperature, acetonitrile (3ml) drips of solution of N-iodosuccinimide (0.158g) is added in acetonitrile (3ml) solution of the preparation example 23 described title compounds (0.218g) under stirring.After 27 hours, with the reaction mixture reduction vaporization, resistates is gone up through the column chromatography purifying in silica gel (5g), makes eluent with methylene dichloride, obtains the described title compound of yellow oily.δ(CDCl 3)：2.11(s，3H)，2.32(s，3H)，7.73(s，2H)。MS (thermal spray): M/Z[M+H] 435.0; C 12H 8Cl 2F 3IN 2+ H theoretical value 434.91.
Preparation example 251-(2,6-dichlor-4-trifluoromethyl phenyl)-3,5-dimethyl-4-vinyl pyrazoles
Preparation example 24 described title compounds (1.0g), three-normal-butyl (vinyl) tin (2ml) and four (triphenyl phosphine) palladium (O) dimethyl formamide (10ml) solution (0.1g) was stirred 2 hours down in 75 ℃, under room temperature, stirred 18 hours then.Successively reaction mixture was stirred 2 hours down in 75 ℃, handle, stirred 2 hours down, (0.1g) handle, stirred 2 hours down and reduction vaporization in 75 ℃ with four (triphenyl phosphine) palladium (O) in 75 ℃ with three-normal-butyl (vinyl) tin (2ml).Resistates is partition between methylene dichloride and water, separates organic phase, water (x2) and salt water washing successively, dry (Na 2SO 4) and reduction vaporization.The gained crude product is adsorbed on the silica gel (20g), goes up through the column chromatography purifying in silica gel (150g) then, use hexane: (100: 0-0: 100) wash-out obtains the described title compound of yellow oily to dichloromethane gradient liquid.δ(CDCl 3)：2.11(s，3H)，2.40(s，3H)，5.23(d，1H)，5.41(d，1H)，6.59(dd，1H)，7.71(s，2H)。MS (thermal spray): M/Z[M+H] 335.1; C 14H 11Cl 2F 3N 2+ H theoretical value 335.03.
Preparation example 265-amino-4-iodo-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles
With 5-amino-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles (WO-A-94/13643 under stirring; 35g) and under the backflow of acetonitrile (450ml) solution of N-iodosuccinimide (29g) heated 1.5 hours, make reaction mixture cooling and reduction vaporization then.Resistates is dissolved in methylene dichloride, and solution is used sodium thiosulfate solution, water and salt water washing successively, dry then (Na 2SO 4) and reduction vaporization.The gained black solid is developed with hexane, obtains the described title compound of greenish orange look solid state, and m.p.135-137 ℃, δ (CDCl 3): 2.25 (s, 3H), 3.67 (br.s, 2H), 7.49 (s, 2H).MS (thermal spray): M/Z[M+H] 401.4; C 10H 7Cl 3IN 3+ H theoretical value 401.88.
Preparation example 274-iodo-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles
Anhydrous tetrahydro furan (50ml) drips of solution of nitrous acid tertiary butyl ester (12ml) is added in anhydrous tetrahydro furan (120ml) solution of the preparation example 26 described title compounds (18.11g) under the stirring, under the gentle reflux.Make reaction mixture cooling and reduction vaporization, then with resistates on silica gel through the column chromatography purifying, use hexane, use hexane subsequently: ethyl acetate (19: 1) is made eluent, obtains the described title compound of orange solids shape, m.p.97-99 ℃, δ (CDCl 3): 2.36 (s, 3H), 7.47 (s, 2H), 7.48 (s, 1H).MS (thermal spray): M/Z[M+H] 386.9; C 10H 6Cl 3IN 2+ H theoretical value 386.87.
Preparation example 284-vinyl-3-methyl isophthalic acid-(2,4, the 6-trichlorophenyl) pyrazoles
Preparation example 27 described title compounds (16.62g), three-normal-butyl (vinyl) tin (27.27g) and four (triphenyl phosphine) palladium (O) anhydrous dimethyl formamide (100ml) solution (0.6g) under stirring was heated 2.5 hours down in 75 ℃, add again four (triphenyl phosphine) palladium (O) (0.6g) and with reaction mixture in 75 ℃ of following reheat 2 hours, reduction vaporization then.Resistates through the column chromatography purifying, is used hexane on silica gel, use hexane then: ethyl acetate (99: 1) is made eluent, obtains the described title compound of faint yellow solid shape, and m.p.71-73 ℃, δ (CDCl 3): 2.40 (s, 3H), 5.19 (d, 1H), 5.49 (d, 1H), 6.59 (dd, 1H), 7.47 (s, 2H), 7.50 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 287.0; C 12H 9Cl 3N 2+ NH 4Theoretical value 286.99.
Preparation example 293-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-trifluoroacetyl group pyrazoles
Nitrous acid tertiary butyl ester (12.45ml) is added drop-wise to 5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-trifluoroacetyl group pyrazoles (JP-A-8-311036 under stirring; Stirred 16 hours down in 55 ℃ in tetrahydrofuran (THF) 30g) (250ml) solution and with mixture.As described below, further add nitrous acid tertiary butyl ester/stirring under 55 ℃ subsequently: 9ml/7 hour, 6ml/16 hour, 9ml/6 hour, 4.75ml/16 hour, 6ml/6 hour and 3.5ml/22 hour.Make reaction mixture cooling and reduction vaporization, the product that the identical preparation example with three of resistates is obtained merges then.Go up through the column chromatography purifying in silica gel (1Kg), use hexane: methylene dichloride (6: 4), make eluent with methylene dichloride then, obtain a yellow oil, with hexane (3 * 50ml), use methylene dichloride (100ml) development subsequently, obtain the described title compound of white solid, m.p.124-125 ℃, δ (CDCl 3): 7.83 (s, 2H), 8.30 (s, 1H).MS (thermal spray): M/Z[M+H] 401.7; C 13H 3Cl 2F 6N 3O+H theoretical value 401.96.
Preparation example 303-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3,3,3-trifluoro propene-2-yl) pyrazoles
Under the room temperature nitrogen atmosphere, the hexane solution (0.11ml) of 2.5 M n-Butyl Lithiums is added drop-wise in tetrahydrofuran (THF) (6ml) suspension that stirs the basic triphenyl phosphonium iodide of Jia down (111mg).Under the room temperature nitrogen atmosphere, be added drop-wise to the gained red tan solution in tetrahydrofuran (THF) (1ml) solution that stirs preparation example 29 described title compounds (100mg) down and with reaction mixture stirring 30 minutes.Add entry (30ml) then, with ether (50ml) extraction, with organic extract liquid drying (Na 2SO 4) and reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (10g), and use hexane: methylene dichloride (1: 1) is made eluent, obtains the described title compound of white solid, and m.p.103-104 ℃, δ (CDCl 3): 6.20 (s, 1H), 6.39 (s, 1H), 7.78 (s, 1H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+H] 399.8; C 14H 5Cl 2F 6N 3+ H theoretical value 400.0.
Preparation example 313-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3-Trifluoromethyl-1-pyrazoline-3-yl) pyrazoles
Under the room temperature, join ether (100ml) solution of diazomethane (40mmol) in ether (150ml) solution that stirs preparation example 30 described title compounds (27g) down lentamente and with mixture stirring 40 minutes.Ether (150ml) solution that adds diazomethane (50mmol) more lentamente, reaction mixture restir 16 hours under room temperature steams and removes excessive diazomethane, and decompression is steamed down and desolventized then, obtains the described title compound of white solid.δ(CDCl 3)：2.23(m，1H)，2.52(m，1H)，4.90(m，2H)，7.78(s，2H)，8.15(s，1H)。MS (thermal spray): M/Z[M+NH 4] 458.8; C 15H 7Cl 2F 6N 5+ NH 4Theoretical value 459.0.
Preparation example 325-chloro-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodine pyrazoles
The dichloromethane solution (2.7ml) of about 1 M nitrosyl chloride is added drop-wise in acetonitrile (15ml) solution that stirs following, ice-cooled preparation example 1 described title compound (1.0g), will heats 10 minutes and reduction vaporization under the reaction mixture refluxed then.Resistates through the column chromatography purifying, is used hexane on silica gel: toluene (2: 1), make eluent with toluene then, and obtain the described title compound of greenish orange look solid state, m.p.115.7-116.3 ℃, δ (CDCl 3): 7.80 (s, 2H).MS (thermal spray): M/Z[M+H] 466.0; C 11H 2Cl 3F 3IN 3+ H theoretical value 465.84.
Preparation example 335-chloro-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl pyrazoles
Under the room temperature, four (triphenyl phosphine) palladium (O) (0.448g) is joined in dimethyl formamide (75ml) solution of the preparation example 32 described title compounds (6.0g) under stirring, after 5 minutes, drip three-normal-butyl (vinyl) tin (11.3ml).The gained mixture is in 70 ℃ of down heating 18 hours, reduction vaporization then, and resistates is partition between ether and water.Separate organic phase, dry and reduction vaporization, gained resistates on silica gel through the column chromatography purifying, use hexane, use hexane then: methylene dichloride (2: 1) is made eluent, crystallization in hexane subsequently, obtain the described title compound of white solid, m.p.69.8-70.4 ℃, δ (CDCl 3): 5.61 (d, 1H), 6.20 (d, 1H), 6.56 (dd, 1H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 383.1; C 13H 5Cl 3F 3N 3+ NH 4Theoretical value 382.98.
Preparation example 345-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-trifluoromethyl pyrazol
According to preparation example 1 described similarity method, obtain a shallow white solid, m.p.126 ℃, δ (CDCl by 5-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-trifluoromethyl pyrazol (WO-A-87/03781) 3): 3.90 (br.s, 2H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+H] 490.2; C 11H 4Cl 2F 6IN 3+ H theoretical value 489.88.
Preparation example 351-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-trifluoromethyl pyrazol
According to preparation example 3 described similarity methods, obtain an oily matter by preparation example 34 described title compounds, it is left standstill curing, crystallization in propan-2-ol obtains the described title compound of yellow solid shape, m.p.109-112 ℃.Measured value: C, 27.87; H, 0.69; N, 6.15.C 11H 4Cl 2F 6IN 3Theoretical value C, 27.82; H, 0.64; N, 5.90%.δ(CDCl 3)：7.70(s，1H)，7.77(s，2H)。
Preparation example 361-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl-3-trifluoromethyl pyrazol
Except with crude product crystallization in hexane, then further on silica gel through the column chromatography purifying, make eluent with ether, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: methyl alcohol: water (40: 10: 50) is made eluent, subsequently in propan-2-ol beyond the crystallization, according to preparation example 4 described similarity methods, obtain by preparation example 35 described title compounds, obtain the described title compound of faint yellow solid shape, m.p.95-98 ℃, δ (CDCl 3): 5.39 (d, 1H), 5.65 (d, 1H), 6.69 (dd, 1H), 7.80 (s, 1H), 7.81 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 391.9; C 13H 6Cl 2F 6N 2+ NH 4Theoretical value 392.02.
Preparation example 375-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-3-phenylpyrazole
With 2, ethanol (2ml) solution of 6-dichlor-4-trifluoromethyl phenyl hydrazine (0.245g) joins in ethanol (8ml) solution that stirs benzoyl acetonitrile (0.145g) down and gained solution is refluxed and heated 6 hours down.Add Glacial acetic acid (1ml), reheat was 6 hours under the gained mixture was refluxed, then reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (10g), makes eluent with methylene dichloride, subsequently on C18 silica gel through the reversed-phase HPLC purifying, use acetonitrile: methyl alcohol; Water (50: 10: 40) is made the wash-out profit, obtains the described title compound of white solid, and m.p.141.5-142.5 ℃, δ (CDCl 3): 3.60 (br.s, 2H), 6.08 (s, 1H), 7.30-7.45 (m, 3H), 7.80 (s, 2H), 7.80-7.85 (m, 2H).MS (thermal spray): M/Z[M+H] 372.1; C 16H 10Cl 2F 3N 2+ H theoretical value 372.03.
Preparation example 385-amino-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-phenylpyrazole
Except reaction mixture was stirred 18 hours, according to preparation example 1 described similarity method, obtain a yellow solid by preparation example 37 described title compounds, m.p.162-164 ℃, δ (CDCl 3): 3.80 (br.s, 2H), 7.35 (m, 3H), 7.78 (s, 2H), 7.95 (m, 2H).MS (thermal spray): M/Z[M+H] 498.1; C 16H 9Cl 2F 3IN 3+ H theoretical value 497.93.
Preparation example 391-(2,6-dichlor-4-trifluoromethyl phenyl)-4-iodo-3-phenylpyrazole
In 65 ℃ in 30 minutes, tetrahydrofuran (THF) (20ml) drips of solution of nitrous acid tertiary butyl ester (3.0g) is added in tetrahydrofuran (THF) (50ml) solution of the preparation example 38 described title compounds (2.5g) under stirring.In under 65 ℃ again after 3 hours, make the reaction mixture cooling, kept 18 hours under the room temperature, then reduction vaporization.Gained oily matter on silica gel through twice column chromatography purifying, at first make eluent with methylene dichloride, use hexane, hexane subsequently successively: ethyl acetate (9: 5) and hexane: ethyl acetate (90: 10) is made eluent, obtain the described title compound of Off-white solid shape, m.p.88-89 ℃, δ (CDCl 3): 7.45 (m, 3H), 7.70 (s, 1H), 7.72 (s, 2H), 7.95 (m, 2H).MS (thermal spray): M/Z[M+H] 482.8; C 16H 8Cl 2F 3IN 2+ NH theoretical value 482.91.
Preparation example 401-(2,6-dichlor-4-trifluoromethyl phenyl)-4-vinyl-3-phenylpyrazole
Under the room temperature, four (triphenyl phosphine) palladium (O) (0.07g) is joined in dimethyl formamide (12ml) solution of the preparation example 39 described title compounds (1.0g) under stirring, after 10 minutes, add three-normal-butyl tin (1.8ml).The gained mixture was heated 6 hours down in 70 ℃, make it under room temperature, leave standstill 18 hours, then reduction vaporization.Resistates is partition between methylene dichloride (50ml) and water (50ml), separates organic phase, dry (MgSO 4) and reduction vaporization.Resistates through twice column chromatography purifying, is at first used the hexane gradient liquid wash-out of ethyl acetate on silica gel, with the hexane gradient liquid wash-out of ether, obtain the described title compound of yellow oily for the second time.δ(CDCl 3)：5.25(d，1H)，5.65(d，1H)，6.80(dd，1H)，7.45(m，3H)，7.75(m，5H)。MS (thermal spray): M/Z[M+H] 383.3; C 18H 11Cl 2F 3N 2+ H theoretical value 383.03.
Preparation example 415-amino-4-chlorine difluoro ethanoyl-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Chlorine difluoroacetic acid acid anhydride (30.37g) is added drop-wise to stir down, ice-refrigerative 5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles (EP-A-0295117; 20.0g) pyridine (200ml) solution in, then reaction mixture was stirred under room temperature 16 hours.Gained mixture concentrating under reduced pressure is removed pyridine (150ml).Stir down, by dripping concentrated hydrochloric acid (30ml) pH of mixture is transferred to 1, with ethyl acetate (2 * 500ml) extractions.The organic extract liquid that merges is washed dry (MgSO with saturated sodium bicarbonate aqueous solution (500ml) 4) and reduction vaporization.Resistates is dissolved in the mixture of tetrahydrofuran (THF) (200ml) and water (50ml), then with solution in 60 ℃ the heating 16 hours, make its cooling, remove tetrahydrofuran (THF) by reduction vaporization.(2 * 300ml) extractions, the organic extract liquid of merging are water (100ml) and salt solution (2 * 100ml) washings, dry (MgSO successively with ethyl acetate 4) and reduction vaporization.The crystallization in propan-2-ol of gained resistates obtains the described title compound of white solid, and m.p.225-226 ℃, δ (CDCl 3): 6.08 (br.s, 2H), 7.84 (s, 2H).MS (thermal spray): M/Z[M+NH 4] 450.1; C 13H 4Cl 3F 5N 4O+NH 4Theoretical value 450.0.
Preparation example 424-chlorine difluoro ethanoyl-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Nitrous acid tertiary butyl ester (12.45ml) is added drop-wise in tetrahydrofuran (THF) (100ml) solution that stirs preparation example 41 described title compounds (13.7g) down and with mixture in 60 ℃ of heating 22 hours down, make also reduction vaporization of its cooling.Resistates is gone up through the column chromatography purifying in silica gel (50g), makes eluent with methylene dichloride, use subsequently hexane (5 * 50ml) development and crystallizations in methylene dichloride obtain the described title compound of white solid, m.p.124-125 ℃, δ (CDCl 3): 7.83 (s, 2H), 8.27 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 435.2; C 13H 3Cl 3F 5N 3O+NH 4Theoretical value 435.0.
Preparation example 434-(3-chloro-3,3-difluoro propylene-2-yl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Under the room temperature nitrogen atmosphere, the hexane solution (3.8ml) of 2.5 M n-Butyl Lithiums is added drop-wise in tetrahydrofuran (THF) (20ml) suspension that stirs the basic triphenyl phosphonium iodide of Jia down (3.817g).Under the room temperature nitrogen atmosphere, be added drop-wise to the gained red tan solution in tetrahydrofuran (THF) (30ml) solution that stirs preparation example 42 described title compounds (3.95g) down and with reaction mixture stirring 1 hour.Add entry (50ml), with ether (2 * 50ml) extractions and with the organic extract liquid drying (Na that merges 2SO 4), reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (100g), and use hexane: methylene dichloride (1: 1) is made eluent, and crystallization in propan-2-ol subsequently obtains the described titleization of white solid, and m.p.113-114 ℃, δ (CDCl 3): 6.12 (s, 1H), 6.20 (s, 1H), 7.75 (s, 2H), 7.80 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 433.0; C 14H 5Cl 3F 5N 3+ NH 4Theoretical value 433.0.
Preparation example 444-(3-chlorodifluoramethyl--1-pyrazoline-3-yl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Under the room temperature, (7.0ml 2.3mmol) is added drop-wise to lentamente in ether (10ml) solution of preparation example 43 described title compounds (800mg) and with mixture and stirred 1 hour with the diethyl ether solution of diazomethane.Under stable nitrogen gas stream, steam and remove excessive diazomethane and solvent, obtain the described title compound of white solid.δ(CDCl 3)：2.27(m，1H)，2.58(m，1H)，4.90(m，2H)，7.75(s，2H)，8.06(s，1H)。MS (thermal spray): M/Z[M+NH 4] 474.8; C 15H 7Cl 3F 3N 5+ NH 4Theoretical value 475.0.
Preparation example 455-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-propionyl pyrazoles
Tosic acid monohydrate (2.92g) is joined tosic acid-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(third-1-alkynes-1-yl) pyrazoles (WO-A-97/07102 under stirring; 2.1g) acetonitrile (40ml) solution in and mixture stirred under room temperature 1 hour.Adding tosic acid monohydrate (1.0g) more also stirred this mixture 16 hours under room temperature.Add acetonitrile (20ml) and tosic acid monohydrate (1.0g) again and continue and stirred 1 hour, will also use ether (2 * 100ml) extractions in the reaction mixture impouring saturated sodium bicarbonate aqueous solution (500ml) then.The organic extract liquid that merges is washed dry (Na with salt solution (100ml) 2SO 4) and reduction vaporization, resistates is gone up through the column chromatography purifying in silica gel (70g) then, makes eluent with methylene dichloride, obtains the described title compound of filbert solid state, and m.p.167-169 ℃, δ (CDCl 3): 1.26 (t, 3H), 3.03 (q, 2H), 5.83 (br.s, 2H), 7.80 (s, 2H).MS (thermal spray): M/Z[M+H] 377.2; C 14H 9Cl 2F 3N 4O+H theoretical value 377.0.
Preparation example 463-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-propionyl pyrazoles
Nitrous acid tertiary butyl ester (0.66ml) is added drop-wise in tetrahydrofuran (THF) (30ml) solution of the preparation example 45 described title compounds (1.2g) under stirring and and under room temperature, stirred 1 hour mixture.Add nitrous acid tertiary butyl ester (0.3ml) again and mixture was stirred under room temperature 1 hour.Then reaction mixture was heated 10 minutes down in 60 ℃, make its cooling and reduction vaporization.Resistates is gone up through the column chromatography purifying in silica gel (50g), makes eluent with methylene dichloride, obtains the very light described title compound of yellow solid shape, and m.p.143 ℃, δ (CDCl 3): 1.28 (m, 3H), 3.01 (q, 2H), 7.80 (s, 2H), 8.15 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 379.3; C 14H 8Cl 2F 3N 3O+NH 4Theoretical value 379.0.
Preparation example 474-(but-1-ene-2-yl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles
Except using hexane: methylene dichloride (2: 3) is made the eluent of chromatogram in separating not subsequently the crystallisation step, according to preparation example 43 described similarity methods, obtains a white solid by preparation example 46 described title compounds, and m.p.104-105 ℃, δ (CDCl 3): 1.19 (t, 3H), 2.47 (q, 2H), 5.29 (s, 1H), 5.74 (s, 1H), 7.60 (s, 1H), 7.79 (s, 2H).MS (electron spray(ES)): M/Z[M+H] 360.1; C 15H 10Cl 2F 3N 3+ H theoretical value 360.0.
Preparation example 483-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-five fluorine propionyl pyrazoles
Under-80 ℃ of nitrogen atmosphere, the hexane solution (2.78ml) of 2.5 M n-Butyl Lithiums is joined in tetrahydrofuran (THF) (80ml) solution of the preparation example 3 described title compounds (3.0g) under stirring, feed rate should make the temperature of reaction mixture be no more than-73 ℃.Mixture was stirred 10 minutes down in-73 ℃, adds the tetrahydrofuran (THF) 5ml of five fluorine methyl propionates (0.89ml) then) solution, feed rate should make the temperature of reaction mixture be no more than-75 ℃.After adding material, made mixture be warmed to room temperature in 1.5 hours, add entry (100ml) then, (2 * 80ml) extract the gained mixture with ethyl acetate.With the organic layer drying (Na that merges 2SO 4) and reduction vaporization, then resistates is gone up through the column chromatography purifying in silica gel (150g), use hexane: methylene dichloride (1: 9) is made eluent, upward be further purified in silica gel (90g) through column chromatography, use hexane: ether (9: 1) is made eluent, obtain the described title compound of white solid, m.p.120 ℃, δ (CDCl 3): 7.80 (s, 2H), 8.25 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 468.9; C 14H 3Cl 2F 8N 3O+NH 4Theoretical value 469.0.
Preparation example 493-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3,3,4,4,4-five fluorine but-1-ene-2-yl) pyrazoles
The crystallisation step after not having chromatographic separation,, obtain a white solid by preparation example 48 described title compounds according to preparation example 43 described similarity methods, m.p.107-108 ℃, δ (CDCl 3): 6.23 (s, 1H), 6.43 (s, 1H), 7.73 (s, 1H), 7.79 (s, 2H).MS (electron spray(ES)): M/Z[M+H] 450.0; C 15H 5Cl 2F 8N 3+ H theoretical value 450.0.
Preparation example 503-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3-pentafluoroethyl group-1-pyrazoline-3-yl) pyrazoles
According to preparation example 44 described similarity methods, obtain a white solid by preparation example 49 described title compounds.δ(CDCl 3)：2.26(m，1H)，2.61(m，1H)，4.83(m，2H)，7.76(s，2H)，7.98(s，1H)。MS (thermal spray): M/Z[M+H] 491.8; C 16H 7Cl 2F 8N 5+ H theoretical value 492.0.
Preparation example 513-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-seven fluorine butyryl radicals pyrazoles
Except use hexane in the chromatographic purification step in the first time: ether (2: 3) was made eluent and use hexane in second step: ether gradient liquid (19: 1-9: 1) the wash-out, according to preparation example 48 described similarity methods, obtain a faint yellow solid by preparation example 3 described title compounds and hyptafluorobutyric acid methyl esters, m.p.102-103 ℃, δ (CDCl 3): 7.80 (s, 2H), 8.24 (s, 1H).MS (thermal spray): M/Z[M+NH 4] 518.7; C 15H 3Cl 2F 10N 3O+NH 4Theoretical value 519.0.
Preparation example 523-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3,3,4,4,5,5,5-seven fluorine penta-1-alkene-2-yl) pyrazoles
Except making eluent with methylene dichloride and use hexane in first time chromatographic purification step in second step: methylene dichloride (1: 1) is made eluent, is not had the crystallisation step subsequently, according to preparation example 43 described similarity methods, obtain a white solid by preparation example 51 described title compounds, m.p.109-110 ℃, δ (CDCl 3): 6.24 (s, 1H), 6.43 (s, 1H), 7.73 (s, 1H), 7.80 (s, 2H).MS (electron spray(ES)): M/Z[M+H] 500.0; C 16H 5Cl 2F 10N 3+ NH theoretical value 500.0.
Preparation example 533-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3-seven fluoropropyls-1-pyrazoline-3-yl) pyrazoles
According to preparation example 44 described similarity methods, obtain a white solid by preparation example 52 described title compounds.δ (CDCl 3): 2.36 (m, 1H), 2.58 (m, 1H), 4.80 (m, 1H), 4.87 (m, white solids.δ(CDCl 3)：2.36(m，1H)，2.58(m，1H)，4.80(m，1H)，4.87(m，1H)，7.77(s，2H)，7.98(s，1H)。MS (thermal spray): M/Z[M+NH 4] 559.3; C 17H 7Cl 2F 10N 5+ NH 4Theoretical value 559.0.
Preparation example 545-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3,3,3-trifluoro propene-2-yl) pyrazoles
Under the nitrogen atmosphere, with 3,3,3-trifluoro propene-2-base zinc bromide: N, N, N ', tetrahydrofuran solution (J.Org.Chem., 1991,56,7336 of N '-Tetramethyl Ethylene Diamine mixture; 4.5ml, 5mmol) join to stir in preparation example 1 described title compound (1.0g) down and four (triphenyl phosphine) palladium (O) anhydrous tetrahydro furan (1.0ml) solution (60mg) and and heated 20 hours down, make its cooling and be poured in the hexane (50ml) under the stirring in 55 ℃ with reaction mixture.The gained mixture is filtered, and filter bed is with ether (50ml) washing and with the organic solvent reduction vaporization that merges.Resistates is in silica gel (40g, use 10g then) go up through twice column chromatography purifying, for the first time use hexane: ether: methylene dichloride (4: 1: 1) is made eluent, use hexane, hexane subsequently successively: ether (4: 1) and hexane: ether: methylene dichloride (4: 1: 1) is made eluent, obtain the very light described title compound of yellow solid shape, m.p.147-148 ℃, δ (CDCl 3): 3.93 (br.s, 2H), 5.96 (s, 1H), 6.24 (s, 1H), 7.78 (s, 2H).MS (thermal spray): M/Z[M+H] 415.0; C 14H 6Cl 2F 6N 4+ H theoretical value 415.0.
Preparation example 555-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(3-Trifluoromethyl-1-pyrazoline-3-yl) pyrazoles
According to preparation example 44 described similarity methods, obtain a white solid by preparation example 54 described title compounds.δ(CDCl 3)：2.28(m，1H)，2.60(m，1H)，4.77(br.s，2H)，4.77(m，1H)，5.02(m?1H)，7.78(s，1H)，7.82(s，1H)。MS (thermal spray): M/Z[M+H] 457.0; C 15H 8Cl 2F 6N 6+ H theoretical value 457.0.
Preparation example 565-amino-1-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-iodine pyrazoles
Under the room temperature, N-iodosuccinimide (10g) is joined 5-amino-1-[(3-chloro-5-trifluoromethyl under stirring) pyridine-2-yl]-3-cyano pyrazole (EP-A-0500209; 7.91g) acetonitrile (100ml) solution in.After 16 hours, with the reaction mixture reduction vaporization, remaining solid is dissolved in methylene dichloride, and gained solution is used sodium thiosulfate solution (x2), water and saturated brine washing, dry (MgSO successively 4) and reduction vaporization, obtain the described title compound of pink solid shape, m.p.107-108 ℃, δ (CDCl 3): 5.15 (br.s, 2H), 8.20 (s, 1H), 8.67 (s, 1H).MS (thermal spray): M/Z[M+H] 413.1; C 10H 4ClF 3IN 3+ H theoretical value 412.9.
Preparation example 571-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-iodine pyrazoles
In mild heat to reflux state, tetrahydrofuran (THF) (30ml) drips of solution of nitrous acid tertiary butyl ester is added in tetrahydrofuran (THF) (90ml) mixture of the preparation example 56 described title compounds (12.5g) under stirring, makes reaction mixture be cooled to room temperature and reduction vaporization then.Resistates through the column chromatography purifying, is used hexane on silica gel: ethyl acetate (4: 1) is made eluent, obtains the described title compound of yellow solid shape, and m.p.104-107 ℃, δ (CDCl 3): 8.20 (s, 1H), 8.70 (s, 1H).MS (thermal spray): M/Z[M+H] 397.8; C 10H 3ClF 3IN 4+ H theoretical value 397.9.
Preparation example 581-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-vinyl pyrazoles
Under the room temperature nitrogen atmosphere, three-normal-butyl (vinyl) tin (9.19g) and four (triphenyl phosphine) palladium (O) (0.3g) are joined in dimethyl formamide (100ml) solution that stirs preparation example 57 described title compounds (10.50g) down and with the gained mixture and heated 16 hours down in 75 ℃, make its cooling then.With the mixture reduction vaporization, resistates is partition between methylene dichloride and water, and isolating organic phase is water (x3) and saturated brine washing successively, dry (MgSO 4) and reduction vaporization.Resistates through the column chromatography purifying, is used hexane on silica gel: ethyl acetate (9: 1) is made eluent, obtains the described title compound of white solid, and m.p.57.5-58.5 ℃, δ (CDCl 3): 5.50 (d, 1H), 5.97 (d, 1H), 6.65 (dd, 1H), 8.20 (s, 1H), 8.35 (s, 1H), 8.70 (s, 1H).MS (thermal spray): M/Z[M+H] 297.9; C 12H 6ClF 3N 4+ H theoretical value 298.0.
Preparation example 595-amino-3-cyano group-4-iodo-1-(2,4, the 6-trichlorophenyl) pyrazoles
With N-iodosuccinimide (17.67g) join in batches 5-amino-3-cyano group-1-(2,4, the 6-trichlorophenyl) pyrazoles under stirring (US 5,232,940; 22.5g) acetonitrile (300ml) solution in and the gained mixture stirred 1 hour reduction vaporization then under room temperature.Resistates is gone up through the chromatography partial purification in silica gel (800g), uses methylene dichloride: and ethyl acetate gradient liquid (100: 0-0: 100) wash-out, obtain a filbert solid, as described below it is further purified.With hexane (25ml) development, obtain a resistates, it is dissolved in methylene dichloride (500ml), this solution with water (500ml) washing, water lotion is with ethyl acetate (500ml) backwash, with the organic solution drying (Na that merges 2SO 4) and reduction vaporization, obtain the described title compound of filbert solid state.δ(DMSO d6)：6.28(br.s，2H)，7.98(s，2H)。MS (thermal spray): M/Z[M+H] 413.0; C 10H 4Cl 3IN 4+ H theoretical value 412.9.
Preparation example 603-cyano group-4-iodo-1-(2,4, the 6-trichlorophenyl) pyrazoles
In 5 minutes, nitrous acid tertiary butyl ester (7.13ml) is added drop-wise in tetrahydrofuran (THF) (400ml) solution of the preparation example 59 described title compounds (15.5g) under stirring, then mixture was stirred under room temperature 1 hour, be warmed to 60 ℃ in 40 minutes, make its cooling and reduction vaporization.Gained incarnadine solid is gone up through the column chromatography purifying in silica gel (500g), makes eluent with methylene dichloride, obtains the light especially described title compound of yellow solid shape.δ(CDCl 3)：7.52(s，2H)，7.67(s，1H)。MS (thermal spray): M/Z[M+NH 4] 414.8; C 10H 3Cl 3IN 3+ NH 4Theoretical value 414.9.
Preparation example 613-cyano group-4-vinyl-1-(2,4, the 6-trichlorophenyl) pyrazoles
With preparation example 60 described title compounds (10.8g), three-normal-butyl (vinyl) tin (20ml), four (triphenyl phosphine) palladium (O) (1.0g) and the mixture of dimethyl formamide (60ml) stirred 3 hours down in 75 ℃, make in its cooling and the impouring water (100ml) under stirring.(2 * 150ml) extractions, extraction liquid water (50ml) washing of merging is reduction vaporization also with ether for the gained mixture.Resistates is by (purifying is carried out in 3 * 25ml) developments with hexane, go up through the column chromatography purifying in silica gel (200g) subsequently, use hexane: the gradient liquid of ethyl acetate (100: 0-50: 50) wash-out, crystallization in hexane-methylene dichloride then obtains the light especially described title compound of gray solid shape.δ(CDCl 3)：5.46(d，1H)，5.92(d，1H)，6.63(dd，1H)，7.51(s，2H)，7.62(s，1H)。MS (thermal spray): M/Z[M+NH 4] 315.0; C 12H 6Cl 3N 3+ NH 4Theoretical value 315.0.

Claims (24)

1. on following formula (I) compound or its medicine, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on the acceptable solvent thing: R wherein 1Be 2,4, the 6-trisubstd phenyl, wherein 2-and 6-substituting group are selected from halogen and 4-substituting group independently of one another and are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls; Or 3,5-Disubstituted pyridine-2-base, wherein the 3-substituting group is that halogen and 5-substituting group are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls; R 3Be can be by hydroxyl or the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, cyano group, C 1-C 5Alkanoyl or phenyl; R 5Be hydrogen, C 1-C 4Alkyl, amino or halogen; R 2And R 4Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, chlorine and bromine perhaps form C with the carbon atom that they connected 3-C 6Cycloalkyl; R 6And R 8Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, chlorine and bromine; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form C with the carbon atom that they connected 5-C 7Cycloalkyl; R 7The C that is hydrogen, can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, or C 1-C 4Alkoxyl group; With n be 0,1 or 2.
2. the described compound of claim 1, wherein R 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-five fluorine sulfenyl phenyl, 2,4,6-trichlorophenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be methyl, ethyl, third-2-base, 1-hydroxyethyl, 2-hydroxypropyl-2-base, difluoromethyl, dichloromethyl, trifluoromethyl, cyano group, formyl radical, ethanoyl or phenyl; R 5Be hydrogen, methyl, amino or chlorine; R 2And R 4Be selected from hydrogen, methyl, fluorine, chlorine and bromine independently of one another, perhaps form cyclopropyl, cyclobutyl or cyclopentyl with the carbon atom that they connected; R 6And R 8Be selected from hydrogen, methyl, chlorine and bromine independently of one another; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form pentamethylene or hexanaphthene with the carbon atom that they connected; And R 7Be hydrogen, methyl, ethyl, trifluoromethyl, chlorodifluoramethyl-, pentafluoroethyl group, seven fluoropropyls or methoxyl group.
3. the described compound of claim 2, wherein R 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-, five fluorine sulfenyl phenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be cyano group; R 5Be hydrogen or amino; R 2And R 4Identical and be hydrogen, chlorine or bromine; R 6And R 8Be hydrogen; And R 7Be hydrogen, trifluoromethyl or chlorodifluoramethyl-.
4. the described compound of claim 3, wherein said formula (I) compound is selected from
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
(-)-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles;
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
4-(1-chlorodifluoramethyl-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
1-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-(2,2-dibromo cyclopropyl)-pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles; With
5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles.
5. animal doctor or Agrotechnical formulation, said preparation contains formula (I) compound or its animal doctor goes up or agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing and the animal doctor goes up or agricultural goes up acceptable diluent or carrier.
6. pharmaceutical composition, said composition contain each pharmaceutically acceptable solvate and pharmaceutically acceptable diluent or carrier of formula (I) compound or its pharmaceutically acceptable salt or they.
7. described animal doctor of claim 5 or Agrotechnical formulation or the described pharmaceutical composition of claim 6, they are suitable for topical application.
8. the animal doctor that formula (I) compound or its animal doctor go up or agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing or contains above-mentioned each material goes up or agricultural goes up acceptable preparation, and it is as the Parasiticidal medicine.
Formula (I) compound or its pharmaceutically acceptable salt or they each pharmaceutically acceptable solvate or contain the pharmaceutical composition of above-mentioned each material, it is as medicine.
10. on formula (I) compound or its medicine or the animal doctor goes up on each the medicine of acceptable salt or they or the animal doctor goes up the acceptable solvent thing or contains above-mentioned each material pharmaceutical composition or the application of veterinary formulation in the parasiticidal medicine of preparation human or animal.
11. following formula (VII) compound:
Figure A9718033400041
Wherein Ar is separately can be by C 1-C 4Alkyl, C 1-C 4The phenyl or naphthyl that alkoxy or halogen replaces arbitrarily; R 5Be hydrogen, C 1-C 4Alkyl or halogen; R 7Be hydrogen or the C that replaced arbitrarily by one or more halogens 1-C 4Alkyl; And R 1And R 3As definition in the above-mentioned claim 1.
12. the described compound of claim 11, wherein Ar is the 4-aminomethyl phenyl.
13. the method for treatment animal (comprising a people) parsitism, this method comprise on formula (I) compound with significant quantity or its medicine or the animal doctor goes up on each the medicine of acceptable salt or they or the last acceptable solvent thing of animal doctor or the pharmaceutical composition or the veterinary formulation that contain above-mentioned each material are treated described animal.
14. the animal doctor that the method for control certain position parsitism, this method comprise that formula (I) compound with significant quantity or its animal doctor go up or agricultural goes up that each animal doctor of acceptable salt or they goes up or agricultural goes up the acceptable solvent thing or contain above-mentioned each material goes up or agricultural upward acceptable preparation described position is handled.
15. the described method of claim 14, wherein said position are skin or the fur of animal, the soil around the perhaps plant surface, or the plant that is prevented and treated.
16. on following formula (I) compound or its medicine, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on the preparation method of acceptable solvent thing:
Figure A9718033400051
R wherein 1Be 2,4, the 6-trisubstd phenyl, wherein 2-and 6-substituting group are selected from halogen and 4-substituting group independently of one another and are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls; Or 3,5-Disubstituted pyridine-2-base, wherein the 3-substituting group is that halogen and 5-substituting group are selected from the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkoxyl group, the S (O) that can be replaced arbitrarily by one or more halogens nC 1-C 4Alkyl, halogen and five fluorine sulfenyls; R 3Be can be by hydroxyl or the C that can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, cyano group, C 1-C 5Alkanoyl or phenyl; R 5Be hydrogen, C 1-C 4Alkyl, amino or halogen; R 2And R 4Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, chlorine and bromine perhaps form C with the carbon atom that they connected 3-C 6Cycloalkyl; R 6And R 8Be selected from hydrogen, C independently of one another 1-C 4Alkyl, fluorine, chlorine and bromine; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form C with the carbon atom that they connected 5-C 7Cycloalkyl; R 7The C that is hydrogen, can be replaced arbitrarily by one or more halogens 1-C 4Alkyl, or C 1-C 4Alkoxyl group; With n be 0,1 or 2; This method comprises, the following formula of processing as described below (II) compound: R wherein 1, R 3, R 5, R 6, R 7And R 8As definition in the above-mentioned formula (I), (a) work as R 2And R 4The both is a chlorine or when being bromine, (i) in the presence of alkali, handles with chloroform or bromofom, or (ii) under pyrolytical condition, handles with aryl trichloromethyl or aryl trisbromomethyl mercury derivative; Perhaps (b) works as R 2And R 4Be hydrogen or C independently of one another 1-C 4During alkyl, (i) in the presence of transition-metal catalyst, handle with corresponding diazonium paraffin, or the (ii) the first step, do not having in the presence of the transition-metal catalyst, with corresponding diazonium paraffin processing, second goes on foot, and the pyrazoline intermediate is carried out thermal decomposition process; At random prepare on the medicine of required product subsequently, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on the acceptable solvent thing.
17. the described method of claim 16, wherein (a) (i) described alkali be the concentrated base metal hydroxides aqueous solution and described being reflected under the phase-transfer catalyst condition, make catalyzer with quaternary ammonium salt, to the reflux temperature of about reaction medium, in suitable solvent, carry out in about room temperature; At (a) ii) described reagent can be that phenyl trichloromethyl mercury or phenyl trisbromomethyl mercury and described being reflected under about 60 ℃ to about 75 ℃ are carried out in suitable solvent; (i) work as R at (b) 2And R 4When the both was hydrogen, described diazonium paraffin was a diazomethane, and described catalyzer is that acid chloride (II) and described being reflected under about room temperature are carried out in suitable solvent; With (ii) work as R at (b) 2And R 4When the both is hydrogen, the first step, described diazonium paraffin is that diazomethane and described being reflected under about room temperature are carried out in suitable solvent, in second step, the thermolysis of isolated pyrazoline is to carry out in suitable solvent under about 135 ℃ to about 145 ℃.
18. the described method of claim 17, wherein (a) (i) described alkali be the concentrated sodium hydroxide aqueous solution, described catalyzer is that benzyltriethylammoinium chloride and described solvent are the methylene dichloride that at random has small amount of ethanol to exist; At (a) (ii) described solvent is toluene, dimethylbenzene or its mixture; (b) (i) described solvent be ether; With (b) (ii) solvent described in the first step be ether, and second the step described in solvent be dimethylbenzene.
19. the preparation method as formula (I) compound of claim 16 definition, this method comprise, at random depress adding, in the presence of transition-metal catalyst, in suitable solvent, in following formula (VIII) compound: R wherein 2, R 4, R 6And R 8As above-mentioned claim 16 definition, an alkali metal salt derivative of the following formula of thermolysis (VII) compound: Wherein Ar is separately can be by C 1-C 4Alkyl, C 1-C 4The phenyl or naphthyl that alkoxy or halogen replaces arbitrarily; R 5Be hydrogen, C 1-C 4Alkyl or halogen; R 7Be hydrogen or the C that replaced arbitrarily by one or more halogens 1-C 4Alkyl; And R 1And R 3As definition in the above-mentioned claim 16;
At random prepare on the medicine of required product subsequently, the animal doctor is last or agriculturely on each the medicine of acceptable salt or they, the animal doctor is last or agriculture on the acceptable solvent thing.
20. the described method of claim 19, wherein said transition-metal catalyst is rhodium acetate (II), described solvent be methylene dichloride and described be reflected at about 101kPa (14.7psi) to about 2757kPa (400psi) pressure down and about room temperature extremely carry out under about 80 ℃ temperature.
21. the described method of arbitrary claim in claim 19 and 20, wherein Ar is the 4-aminomethyl phenyl.
22. the described method of arbitrary claim, wherein R among the claim 16-21 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-five fluorine sulfenyl phenyl, 2,4,6-trichlorophenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be methyl, ethyl, third-2-base, 1-hydroxyethyl, 2-hydroxypropyl-2-base, difluoromethyl, dichloromethyl, trifluoromethyl, cyano group, formyl radical, ethanoyl or phenyl; R 5Be hydrogen, methyl, amino or chlorine; R 2And R 4Be selected from hydrogen, methyl, fluorine, chlorine and bromine independently of one another, perhaps form cyclopropyl, cyclobutyl or cyclopentyl with the carbon atom that they connected; R 6And R 8Be selected from hydrogen, methyl, chlorine and bromine independently of one another; Perhaps, work as R 2And R 4When not constituting cycloalkyl moiety, R 2And R 6Can form pentamethylene or hexanaphthene group with the carbon atom that they connected; And R 7Be hydrogen, methyl, ethyl, trifluoromethyl, chlorodifluoramethyl-, pentafluoroethyl group, seven fluoropropyls or methoxyl group.
23. the described method of claim 22, wherein R 1Be 2,6-dichlor-4-trifluoromethyl phenyl, 2,6-two chloro-4-, five fluorine sulfenyl phenyl or 3-chloro-5-5-flumethiazine-2-base; R 3Be cyano group; R 5Be hydrogen or amino; R 2And R 4Identical and be hydrogen, chlorine or bromine; R 6And R 8Be hydrogen; And R 7Be hydrogen, trifluoromethyl or chlorodifluoramethyl-.
24. the described method of claim 23, wherein said formula (I) compound is selected from
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
(-)-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles;
3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles;
3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
4-(1-chlorodifluoramethyl-cyclopropyl)-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
1-[(3-chloro-5-trifluoromethyl) pyridine-2-yl]-3-cyano group-4-(2,2-dibromo cyclopropyl)-pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dibromo cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles;
5-amino-3-cyano group-4-(2,2-dichloro cyclopropyl)-1-(2,6-two chloro-4-five fluorine sulfenyl phenyl) pyrazoles; With
5-amino-3-cyano group-1-(2,6-dichlor-4-trifluoromethyl phenyl)-4-(1-trifluoromethyl cyclopropyl) pyrazoles.
CN97180334A 1996-12-05 1997-11-25 Parasiticidal pyrazoles Expired - Fee Related CN1106386C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9625290.3A GB9625290D0 (en) 1996-12-05 1996-12-05 Parasiticidal agents
GB9625290.3 1996-12-05
GB9702235.4 1997-02-04
GBGB9702235.4A GB9702235D0 (en) 1997-02-04 1997-02-04 Parasiticidal agents
GBGB9712045.5A GB9712045D0 (en) 1997-06-10 1997-06-10 Parasiticidal agents
GB9712045.5 1997-06-10

Publications (2)

Publication Number Publication Date
CN1258282A true CN1258282A (en) 2000-06-28
CN1106386C CN1106386C (en) 2003-04-23

Family

ID=27268619

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97180334A Expired - Fee Related CN1106386C (en) 1996-12-05 1997-11-25 Parasiticidal pyrazoles

Country Status (40)

Country Link
US (2) US6075043A (en)
EP (1) EP0946515B1 (en)
JP (2) JP3950483B2 (en)
KR (1) KR100354311B1 (en)
CN (1) CN1106386C (en)
AR (1) AR013879A1 (en)
AT (1) ATE233736T1 (en)
AU (1) AU720705B2 (en)
BG (1) BG64127B1 (en)
BR (1) BR9713565A (en)
CA (1) CA2273951C (en)
CO (1) CO5031251A1 (en)
CZ (1) CZ295295B6 (en)
DE (1) DE69719547T2 (en)
DK (1) DK0946515T3 (en)
DZ (1) DZ2360A1 (en)
EA (1) EA002278B1 (en)
ES (1) ES2191870T3 (en)
HK (1) HK1029111A1 (en)
HR (1) HRP970663B1 (en)
HU (1) HUP0000544A3 (en)
ID (1) ID21556A (en)
IL (1) IL129866A (en)
IS (1) IS1982B (en)
MA (1) MA24414A1 (en)
MY (1) MY117021A (en)
NO (2) NO992736D0 (en)
NZ (1) NZ335611A (en)
OA (1) OA11055A (en)
PA (1) PA8442101A1 (en)
PE (1) PE20199A1 (en)
PL (1) PL190926B1 (en)
PT (1) PT946515E (en)
RS (1) RS49720B (en)
SK (1) SK285203B6 (en)
TN (1) TNSN97197A1 (en)
TW (1) TW524667B (en)
UA (1) UA60321C2 (en)
UY (2) UY24798A1 (en)
WO (1) WO1998024767A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101300230B (en) * 2005-11-03 2011-04-13 诺瓦提斯公司 N-(hetero) aryl indole derivatives as pesticides
CN111116478A (en) * 2019-12-18 2020-05-08 浙江金伯士药业有限公司 Preparation method of antibiotic virginiamycin intermediate for livestock
CN115894374A (en) * 2023-02-16 2023-04-04 广州佳途科技股份有限公司 Preparation method and application of fluorocarbonitrile

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW524667B (en) 1996-12-05 2003-03-21 Pfizer Parasiticidal pyrazoles
GB9801851D0 (en) * 1998-01-29 1998-03-25 Pfizer Ltd Parasiticidal agents
GB9811050D0 (en) * 1998-05-22 1998-07-22 Pfizer Ltd Pyrazoles
AR021608A1 (en) * 1998-12-11 2002-07-31 Merial Ltd REPRESSION OF ARTROPODES IN ANIMALS
US6531501B1 (en) 1998-12-11 2003-03-11 Aventis Cropscience, S.A. Control of arthropods in animals
GB9916052D0 (en) * 1999-07-08 1999-09-08 Pfizer Ltd Anthelmintic compositions
JP2003516941A (en) 1999-12-02 2003-05-20 アベンティス クロップサイエンス ソシエテ アノニム Arthropod control in animals
WO2003076409A1 (en) * 2002-03-14 2003-09-18 Syngenta Participations Ag Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
CH697663B1 (en) * 2003-01-07 2009-01-15 Lanxess Deutschland Gmbh Pyrazolylalkine.
WO2005023773A1 (en) * 2003-09-04 2005-03-17 Pfizer Limited Process for the preparation of substituted aryl pyrazoles
US7514464B2 (en) * 2003-12-18 2009-04-07 Pfizer Limited Substituted arylpyrazoles
GB0329314D0 (en) 2003-12-18 2004-01-21 Pfizer Ltd Substituted arylpyrazoles
EP1735284A1 (en) 2004-03-18 2006-12-27 Pfizer Limited N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
US20080146643A1 (en) * 2005-06-15 2008-06-19 Pfizer Limited Combination
US20080176865A1 (en) * 2005-06-15 2008-07-24 Pfizer Limited Substituted arylpyrazoles
US7645786B2 (en) 2005-06-15 2010-01-12 Pfizer Inc. Substituted arylpyrazoles
US20070149464A1 (en) * 2005-06-15 2007-06-28 Pfizer Inc. Combination
EA200702497A1 (en) 2005-06-15 2008-06-30 Пфайзер Лимитед SUBSTITUTED Arylpyrazoles for use against parasites
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
DE102006061538A1 (en) * 2006-12-27 2008-07-03 Bayer Healthcare Ag Agent for controlling parasites on animals comprises an N-phenylpyrazole, a pyrethroid, an aliphatic cyclic carbonate and an aliphatic polyether
DE102006061537A1 (en) 2006-12-27 2008-07-03 Bayer Healthcare Ag Agent for controlling parasites on animals comprises an N-phenylpyrazole, an aliphatic cyclic carbonate and an aliphatic polyether
CA2794428A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5-diphenyl-isoxazoline derivatives as insecticides and acaricides
KR101508862B1 (en) 2010-08-05 2015-04-07 조에티스 엘엘씨 Isoxazoline derivatives as antiparasitic agents
EP2619189B1 (en) 2010-09-24 2020-04-15 Zoetis Services LLC Isoxazoline oximes as antiparasitic agents
CA2828397C (en) 2011-03-10 2015-10-13 Zoetis Llc Spirocyclic isoxazoline derivatives as antiparasitic agents
CN103562190A (en) 2011-03-22 2014-02-05 佐蒂斯有限责任公司 Isoxazoline derivatives as antiparasitic agents
BR112013033914A2 (en) 2011-06-30 2016-11-22 Hansen Ab Gmbh agent for the control of parasites in animals and use of an agent
RU2014131951A (en) 2012-02-03 2016-03-27 Зоэтис Ллс ASETHIDINE DIHYDROFURANE DERIVATIVES AS ANTI-PARASITIC AGENTS
JO3626B1 (en) 2012-02-23 2020-08-27 Merial Inc Topical compositions comprising fipronil and permethrin and methods of use
AU2013259847B2 (en) 2012-05-09 2015-09-03 Zoetis Services Llc Azetidine derivatives as antiparasitic agents
MX363173B (en) 2012-12-12 2019-03-12 Zoetis Services Llc Phenylpyrazole injectable compositions.
PE20211202A1 (en) 2017-08-24 2021-07-05 Novo Nordisk As COMPOSITIONS OF GLP-1 AND ITS USES
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658725A1 (en) * 1976-12-24 1978-07-06 Bayer Ag AGENT FOR CONTROLLING ANIMAL EECTOPARASITES WITH A STRONG RESIDUAL EFFECT
US4479968A (en) 1980-10-17 1984-10-30 The Wellcome Foundation Ltd. Control of ectoparasitic infestations of pigs
GB2086302A (en) * 1980-10-24 1982-05-12 Bone Cravens Ltd Prefill Valve System
GB8713769D0 (en) * 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
US5547974A (en) * 1985-12-20 1996-08-20 Rhone-Poulenc Agriculture Ltd. Derivatives of N-phenylpyrazoles
GB8531485D0 (en) * 1985-12-20 1986-02-05 May & Baker Ltd Compositions of matter
US5232940A (en) * 1985-12-20 1993-08-03 Hatton Leslie R Derivatives of N-phenylpyrazoles
GB8713768D0 (en) * 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
GB8613914D0 (en) * 1986-06-07 1986-07-09 Coopers Animal Health Liquid formulations
DE3771318D1 (en) * 1986-12-05 1991-08-14 Ciba Geigy Ag EECTOPARASITICIDAL NON-AQUE POUR-ON LIQUID FORMULATION.
DE3706993A1 (en) * 1987-03-05 1988-09-15 Bayer Ag 5-AMINO-3-HALOGENALKYL-1-ARYL-PYRAZOLE
SE455750B (en) 1987-06-11 1988-08-01 Ericsson Telefon Ab L M DIGITAL TIME MULTIPLEXT MOBILE PHONE SYSTEM WITH AN EFFECTIVE USE OF EVERY TIME FRAME
GB9120641D0 (en) * 1991-09-27 1991-11-06 Ici Plc Heterocyclic compounds
ZA94170B (en) * 1993-01-20 1995-03-15 Soltec Res Pty Ltd Ectoparasiticidal formulation
AUPM437194A0 (en) * 1994-03-11 1994-03-31 Commonwealth Scientific And Industrial Research Organisation Pesticide formulation
ES2221934T3 (en) 1995-08-11 2005-01-16 Novozymes A/S NEW LIPOLITIC ENZYMES.
GB9601128D0 (en) * 1995-08-11 1996-03-20 Pfizer Ltd Parasiticidal compounds
JPH0987111A (en) * 1995-09-27 1997-03-31 Sumitomo Chem Co Ltd Poisonous bait agent for controlling insect pest
FR2739255B1 (en) * 1995-09-29 1998-09-04 Rhone Merieux PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
ATE236883T1 (en) * 1995-12-19 2003-04-15 Bayer Cropscience Sa NEW 1-ARYL PYRAZOLE DERIVATIVES AND THEIR USE AS PEST CONTROLS
GR1002899B (en) * 1996-03-29 1998-05-11 Rhone Merieux Collar against fleas and ticks for dogs and cats using n-phenylpyrazol
IE970215A1 (en) * 1996-03-29 1997-10-08 Rhone Merieux Direct pour-on skin solution for antiparasitic use in cattle¹and sheep
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
GR970100096A (en) * 1996-03-29 1997-11-28 Merial External device against cattle parasites based on n-phenylpyrazol, ear rings
TW524667B (en) 1996-12-05 2003-03-21 Pfizer Parasiticidal pyrazoles
US7100379B2 (en) * 2003-08-14 2006-09-05 Samsung Electronics Co., Ltd. Water supply control apparatus and method for ice maker

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101300230B (en) * 2005-11-03 2011-04-13 诺瓦提斯公司 N-(hetero) aryl indole derivatives as pesticides
CN111116478A (en) * 2019-12-18 2020-05-08 浙江金伯士药业有限公司 Preparation method of antibiotic virginiamycin intermediate for livestock
CN111116478B (en) * 2019-12-18 2021-10-26 浙江金伯士药业有限公司 Preparation method of antibiotic virginiamycin intermediate for livestock
CN115894374A (en) * 2023-02-16 2023-04-04 广州佳途科技股份有限公司 Preparation method and application of fluorocarbonitrile

Also Published As

Publication number Publication date
NZ335611A (en) 2001-01-26
NO992732D0 (en) 1999-06-04
TNSN97197A1 (en) 2005-03-15
ID21556A (en) 1999-06-24
CZ195199A3 (en) 2000-08-16
HUP0000544A3 (en) 2002-01-28
NO992736D0 (en) 1999-06-04
EA002278B1 (en) 2002-02-28
IL129866A0 (en) 2000-02-29
US6075043A (en) 2000-06-13
EP0946515B1 (en) 2003-03-05
UY24798A1 (en) 2000-09-29
ES2191870T3 (en) 2003-09-16
HK1029111A1 (en) 2001-03-23
PL190926B1 (en) 2006-02-28
CN1106386C (en) 2003-04-23
BG64127B1 (en) 2004-01-30
IS5050A (en) 1999-05-11
BR9713565A (en) 2000-03-14
DE69719547D1 (en) 2003-04-10
SK285203B6 (en) 2006-08-03
PA8442101A1 (en) 2000-05-24
ATE233736T1 (en) 2003-03-15
JP3950483B2 (en) 2007-08-01
PT946515E (en) 2003-06-30
YU25299A (en) 2002-10-18
JP2000505812A (en) 2000-05-16
HRP970663B1 (en) 2003-10-31
DK0946515T3 (en) 2003-07-14
CA2273951A1 (en) 1998-06-11
UA60321C2 (en) 2003-10-15
RS49720B (en) 2007-12-31
CO5031251A1 (en) 2001-04-27
PE20199A1 (en) 1999-03-05
KR20000057432A (en) 2000-09-15
CZ295295B6 (en) 2005-06-15
PL333922A1 (en) 2000-01-31
CA2273951C (en) 2003-04-01
AU720705B2 (en) 2000-06-08
AR013879A1 (en) 2001-01-31
MA24414A1 (en) 1998-07-01
DZ2360A1 (en) 2002-12-28
UY24923A1 (en) 1998-09-01
EA199900447A1 (en) 2000-02-28
AU5485998A (en) 1998-06-29
TW524667B (en) 2003-03-21
MY117021A (en) 2004-04-30
IL129866A (en) 2004-05-12
DE69719547T2 (en) 2003-10-02
HRP970663A2 (en) 1998-10-31
BG103454A (en) 2000-01-31
KR100354311B1 (en) 2002-09-28
NO313518B1 (en) 2002-10-14
OA11055A (en) 2002-03-07
JP2007211016A (en) 2007-08-23
WO1998024767A1 (en) 1998-06-11
SK74099A3 (en) 2001-02-12
IS1982B (en) 2005-01-14
NO992732L (en) 1999-08-05
US6268509B1 (en) 2001-07-31
EP0946515A1 (en) 1999-10-06
HUP0000544A2 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
CN1106386C (en) Parasiticidal pyrazoles
CN1159298C (en) Parasiticidal compound
CN1025811C (en) Pesticidal method using N-phenyl pyrazoles
CN1031238C (en) Pesticidal 3-cyano-5-aloxy-1-arylpyrazoles
CN1099415C (en) Pesticidal 1-arylpyrazoles
CN1027341C (en) N-phenylpyrazole derivatives
CN1063283A (en) 1-(2-pyridyl) pyrazoles agricultural chemicals
CN1705668A (en) Heterocyclocarboxamide derivatives
CN1371373A (en) Pyrazole derivatives and processes for producing the same, and pesticides containing the same as the active ingredient
CN1141032A (en) Pesticides
CN1057050A (en) 1-arylpyrrole insecticidal medicine
CN1107673C (en) Pesticidal 1-aryl-3-iminopyrazoles
CN87106207A (en) Contain 2 of triazolyl or imidazolyl, the derivative of 5-dihydrofuran, its preparation method and as the purposes of mycocide
EP0933363B1 (en) Parasiticidal pyrazoles
CN1031373A (en) Pyrimidine derivatives and its preparation method
CN1037705A (en) The preparation method of new pyrimidone derivatives
JPH11514014A (en) Pyrazole, a parasiticide
CN1113238A (en) Substituted pyrazoline derivatives
CN87108356A (en) Pyrimidine derivatives
CN1030577A (en) Disinsection method with 2-phenylimidazole derivative
CN1023476C (en) Process of preparing trifluoromethylvinyl derivatives starting with appropriate halogenovinyl derivatives
CN87102121A (en) Heterogeneous ring compound
CN1079462A (en) New 7-ethynyl-α-(methoxyl group methylene radical)-1-naphthylacetic acid derivant and preparation method thereof and as sterilant
CN1050193A (en) The 13-alkyl-23-imino of LL-F28249 compound and 13-halo-23-imino derivative and their are as killing in the body and vermin, desinsection, kill the use of mite and nematocides
CN86108283A (en) Microbicide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030423

Termination date: 20121125